BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462-1471. [PMID: 17120402 DOI: 10.4065/81.11.1462] [Cited by in Crossref: 410] [Cited by in F6Publishing: 357] [Article Influence: 27.3] [Reference Citation Analysis]
Number Citing Articles
1 Andersen V, Ernst A, Christensen J, Østergaard M, Jacobsen BA, Tjønneland A, Krarup HB, Vogel U. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Med Genet 2010;11:82. [PMID: 20509889 DOI: 10.1186/1471-2350-11-82] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
2 Song EM, Kim N, Lee SH, Chang K, Hwang SW, Park SH, Yang DH, Byeon JS, Myung SJ, Yang SK, Ye BD. Clinical characteristics and long-term prognosis of elderly-onset Crohn's disease. Scand J Gastroenterol 2018;53:417-25. [PMID: 29457917 DOI: 10.1080/00365521.2018.1437927] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Perricone C, Versini M, Ben-ami D, Gertel S, Watad A, Segel MJ, Ceccarelli F, Conti F, Cantarini L, Bogdanos DP, Antonelli A, Amital H, Valesini G, Shoenfeld Y. Smoke and autoimmunity: The fire behind the disease. Autoimmunity Reviews 2016;15:354-74. [DOI: 10.1016/j.autrev.2016.01.001] [Cited by in Crossref: 97] [Cited by in F6Publishing: 79] [Article Influence: 19.4] [Reference Citation Analysis]
4 Li J, Wu N, Yang H, Tang H, Bao D, Ji J. Interaction between STAT3 gene polymorphisms and smoking on Crohn’s disease susceptibility: a case–control study in a Chinese Han population. Inflamm Res 2016;65:573-8. [DOI: 10.1007/s00011-016-0941-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Zabana Y, Garcia-planella E, Van Domselaar M, Mañosa M, Gordillo J, López San Román A, Cabré E, Domènech E. Does active smoking really influence the course of Crohn's disease? A retrospective observational study. Journal of Crohn's and Colitis 2013;7:280-5. [DOI: 10.1016/j.crohns.2012.03.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
6 Yamamoto T, Watanabe T. Strategies for the prevention of postoperative recurrence of Crohn's disease. Colorectal Dis. 2013;15:1471-1480. [PMID: 23809911 DOI: 10.1111/codi.12326] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
7 Scoville EA, Tindle HA, Wells QS, Peyton SC, Gurwara S, Pointer SO, Horst SN, Schwartz DA, Adams DW, Freiberg MS, Gatskie V, King S, Abney LR, Beaulieu DB. Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study. PLoS One 2020;15:e0230656. [PMID: 32214373 DOI: 10.1371/journal.pone.0230656] [Reference Citation Analysis]
8 Aamodt G, Bengtson MB, Vatn MH. Can temperature explain the latitudinal gradient of ulcerative colitis? Cohort of Norway. BMC Public Health. 2013;13:530. [PMID: 23724802 DOI: 10.1186/1471-2458-13-530] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
9 Zoeckler JM, Cibula DA, Morley CP, Lax MB. Predictors for return to work for those with occupational respiratory disease: clinical and structural factors. Am J Ind Med 2013;56:1371-82. [PMID: 24114854 DOI: 10.1002/ajim.22251] [Reference Citation Analysis]
10 Maldifassi MC, Atienza G, Arnalich F, López-Collazo E, Cedillo JL, Martín-Sánchez C, Bordas A, Renart J, Montiel C. A new IRAK-M-mediated mechanism implicated in the anti-inflammatory effect of nicotine via α7 nicotinic receptors in human macrophages. PLoS One 2014;9:e108397. [PMID: 25259522 DOI: 10.1371/journal.pone.0108397] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
11 Malesza IJ, Malesza M, Krela-Kaźmierczak I, Zielińska A, Souto EB, Dobrowolska A, Eder P. Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults. Int J Mol Sci 2020;21:E5223. [PMID: 32718006 DOI: 10.3390/ijms21155223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
12 Calabrese E, Yanai H, Shuster D, Rubin DT, Hanauer SB. Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. J Crohns Colitis 2012;6:756-62. [PMID: 22398093 DOI: 10.1016/j.crohns.2011.12.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
13 Lee S, Metcalfe A, Raman M, Leung Y, Aghajafari F, Letourneau N, Panaccione R, Kaplan GG, Seow CH. Pregnant Women with Inflammatory Bowel Disease Are at Increased Risk of Vitamin D Insufficiency: A Cross-Sectional Study. J Crohns Colitis 2018;12:702-9. [PMID: 29546360 DOI: 10.1093/ecco-jcc/jjy030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
14 Ajslev TA, Sorensen TI, Jess T. Maternal inflammatory bowel disease and offspring body size: a prospective cohort study. Inflamm Bowel Dis 2012;18:709-17. [PMID: 21618364 DOI: 10.1002/ibd.21780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 Kasperczuk A, Daniluk J, Dardzinska A. Smart Model to Distinguish Crohn’s Disease from Ulcerative Colitis. Applied Sciences 2019;9:1650. [DOI: 10.3390/app9081650] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
16 Østergaard M, Ernst A, Labouriau R, Dagiliené E, Krarup HB, Christensen M, Thorsgaard N, Jacobsen BA, Tage-Jensen U, Overvad K. Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population. Scand J Gastroenterol. 2009;44:65-73. [PMID: 18819034 DOI: 10.1080/00365520802400826] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
17 Lee PN. Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol. 2011;59:197-214. [PMID: 21163315 DOI: 10.1016/j.yrtph.2010.12.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 7.5] [Reference Citation Analysis]
18 Levine YA, Faltys M, Zitnik R. Activation of the Inflammatory Reflex in Rheumatoid Arthritis and Inflammatory Bowel Disease; Preclinical Evidence. Neuromodulation. Elsevier; 2018. pp. 1493-502. [DOI: 10.1016/b978-0-12-805353-9.00126-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Lang BM, Biedermann L, van Haaften WT, de Vallière C, Schuurmans M, Begré S, Zeitz J, Scharl M, Turina M, Greuter T, Schreiner P, Heinrich H, Kuntzen T, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B; Swiss IBD Cohort Study Group. Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease. Aliment Pharmacol Ther 2018;47:55-66. [PMID: 29052254 DOI: 10.1111/apt.14378] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
20 Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;389:1741-1755. [PMID: 27914655 DOI: 10.1016/s0140-6736(16)31711-1] [Cited by in Crossref: 615] [Cited by in F6Publishing: 247] [Article Influence: 123.0] [Reference Citation Analysis]
21 Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn's disease. Dis Mon. 2018;64:20-57. [PMID: 28826742 DOI: 10.1016/j.disamonth.2017.07.001] [Cited by in Crossref: 108] [Cited by in F6Publishing: 77] [Article Influence: 27.0] [Reference Citation Analysis]
22 Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology. 2013;145:970-977. [PMID: 23912083 DOI: 10.1053/j.gastro.2013.07.050] [Cited by in Crossref: 290] [Cited by in F6Publishing: 224] [Article Influence: 36.3] [Reference Citation Analysis]
23 Preiss JC, Bokemeyer B, Siegmund B, Stange EF, Zeitz M, Hoffmann JC. [Clinical practice guideline on diagnosis and treatment of Crohn‘s disease - summary for the general practitioner]. Med Klin (Munich). 2009;104:237-243. [PMID: 19337714 DOI: 10.1007/s00063-009-1037-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Bagaitkar J, Demuth DR, Scott DA. Tobacco use increases susceptibility to bacterial infection. Tob Induc Dis 2008;4:12. [PMID: 19094204 DOI: 10.1186/1617-9625-4-12] [Cited by in Crossref: 150] [Cited by in F6Publishing: 124] [Article Influence: 11.5] [Reference Citation Analysis]
25 Ratajczak AE, Szymczak-Tomczak A, Rychter AM, Zawada A, Dobrowolska A, Krela-Kaźmierczak I. Impact of Cigarette Smoking on the Risk of Osteoporosis in Inflammatory Bowel Diseases. J Clin Med 2021;10:1515. [PMID: 33916465 DOI: 10.3390/jcm10071515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Andersen V, Ernst A, Sventoraityte J, Kupcinskas L, Jacobsen BA, Krarup HB, Vogel U, Jonaitis L, Denapiene G, Kiudelis G. Assessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study. BMC Med Genet. 2011;12:139. [PMID: 21995314 DOI: 10.1186/1471-2350-12-139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
27 Lee HS, Kim K, Jung S, Hong M, Kim BM, Yoo DS, Moon JW, Baek J, Hwang SW, Park SH, Yang SK, Han B, Song K, Ye BD. Effects of smoking on the association of human leukocyte antigen with ulcerative colitis. J Gastroenterol Hepatol 2019;34:1777-83. [PMID: 31038770 DOI: 10.1111/jgh.14695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Bager P, Gørtz S, Feenstra B, Nyboe Andersen N, Jess T, Frisch M, Melbye M. Increased Risk of Inflammatory Bowel Disease in Families with Tonsillectomy: A Danish National Cohort Study. Epidemiology 2019;30:256-62. [PMID: 30461527 DOI: 10.1097/EDE.0000000000000946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
29 Jezernik G, Potočnik U. Comprehensive genetic study of fatty acids helps explain the role of noncoding inflammatory bowel disease associated SNPs and fatty acid metabolism in disease pathogenesis. Prostaglandins, Leukotrienes and Essential Fatty Acids 2018;130:1-10. [DOI: 10.1016/j.plefa.2018.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
30 Pedersen N, Duricova D, Elkjaer M, Gamborg M, Munkholm P, Jess T. Risk of extra-intestinal cancer in inflammatory bowel disease: Meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010;105:1480-1487. [PMID: 20332773 DOI: 10.1038/ajg.2009.760] [Cited by in Crossref: 158] [Cited by in F6Publishing: 130] [Article Influence: 14.4] [Reference Citation Analysis]
31 Hughes MC, Olsen CM, Williams GM, Green AC. A prospective study of cigarette smoking and basal cell carcinoma. Arch Dermatol Res 2014;306:851-6. [PMID: 25234270 DOI: 10.1007/s00403-014-1503-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
32 Fawkner-Corbett D, Simmons A, Parikh K. Microbiome, pattern recognition receptor function in health and inflammation. Best Pract Res Clin Gastroenterol. 2017;31:683-691. [PMID: 29566912 DOI: 10.1016/j.bpg.2017.11.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
33 To N, Gracie DJ, Ford AC. Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease. Aliment Pharmacol Ther. 2016;43:549-561. [PMID: 26749371 DOI: 10.1111/apt.13511] [Cited by in Crossref: 88] [Cited by in F6Publishing: 71] [Article Influence: 17.6] [Reference Citation Analysis]
34 Daniluk J, Daniluk U, Reszec J, Rusak M, Dabrowska M, Dabrowski A. Protective effect of cigarette smoke on the course of dextran sulfate sodium-induced colitis is accompanied by lymphocyte subpopulation changes in the blood and colon. Int J Colorectal Dis 2017;32:1551-9. [PMID: 28812128 DOI: 10.1007/s00384-017-2882-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
35 Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis 2008;23:1213-21. [PMID: 18762954 DOI: 10.1007/s00384-008-0542-9] [Cited by in Crossref: 164] [Cited by in F6Publishing: 149] [Article Influence: 12.6] [Reference Citation Analysis]
36 Lim D, Kim W, Lee C, Bae H, Kim J. Macrophage Depletion Protects against Cigarette Smoke-Induced Inflammatory Response in the Mouse Colon and Lung. Front Physiol 2018;9:47. [PMID: 29483875 DOI: 10.3389/fphys.2018.00047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
37 Vatn MH. Natural history and complications of IBD. Curr Gastroenterol Rep. 2009;11:481-487. [PMID: 19903424 DOI: 10.1007/s11894-009-0073-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
38 Hansen TS, Jess T, Vind I, Elkjaer M, Nielsen MF, Gamborg M, Munkholm P. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis. 2011;5:577-584. [PMID: 22115378 DOI: 10.1016/j.crohns.2011.05.010] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 8.6] [Reference Citation Analysis]
39 Kridin K, Zamir H, Cohen AD. Cigarette smoking associates inversely with a cluster of two autoimmune diseases: ulcerative colitis and pemphigus. Immunol Res 2018;66:555-6. [DOI: 10.1007/s12026-018-9021-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
40 Yen EF, Pokhrel B, Du H, Nwe S, Bianchi L, Witt B, Hall C. Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis. 2012;18:1835-1841. [PMID: 22147506 DOI: 10.1002/ibd.22838] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
41 Park S, Chun J, Han KD, Soh H, Kang EA, Lee HJ, Im JP, Kim JS. Dose-response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study. J Gastroenterol. 2019;54:881-890. [PMID: 31093771 DOI: 10.1007/s00535-019-01589-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
42 Murdaca G, Greco M, Borro M, Gangemi S. Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms. Autoimmun Rev 2021;20:102845. [PMID: 33971339 DOI: 10.1016/j.autrev.2021.102845] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Chu KM, Watermeyer G, Shelly L, Janssen J, May TD, Brink K, Benefeld G, Li X. Childhood helminth exposure is protective against inflammatory bowel disease: a case control study in South Africa. Inflamm Bowel Dis. 2013;19:614-620. [PMID: 23380935 DOI: 10.1097/mib.0b013e31827f27f4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
44 Schultz BM, Salazar GA, Paduro CA, Pardo-Roa C, Pizarro DP, Salazar-Echegarai FJ, Torres J, Riedel CA, Kalergis AM, Álvarez-Lobos MM, Bueno SM. Persistent Salmonella enterica serovar Typhimurium Infection Increases the Susceptibility of Mice to Develop Intestinal Inflammation. Front Immunol 2018;9:1166. [PMID: 29896196 DOI: 10.3389/fimmu.2018.01166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
45 Wei S, Sollano J, Hui YT, Yu W, Santos Estrella PV, Llamado LJQ, Koram N. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Review of Gastroenterology & Hepatology 2021;15:275-89. [DOI: 10.1080/17474124.2021.1840976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Biedermann L, Zeitz J, Mwinyi J, Sutter-Minder E, Rehman A, Ott SJ, Steurer-Stey C, Frei A, Frei P, Scharl M, Loessner MJ, Vavricka SR, Fried M, Schreiber S, Schuppler M, Rogler G. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One 2013;8:e59260. [PMID: 23516617 DOI: 10.1371/journal.pone.0059260] [Cited by in Crossref: 206] [Cited by in F6Publishing: 191] [Article Influence: 25.8] [Reference Citation Analysis]
47 Opstelten JL, Beelen RMJ, Leenders M, Hoek G, Brunekreef B, van Schaik FDM, Siersema PD, Eriksen KT, Raaschou-Nielsen O, Tjønneland A, Overvad K, Boutron-Ruault MC, Carbonnel F, de Hoogh K, Key TJ, Luben R, Chan SSM, Hart AR, Bueno-de-Mesquita HB, Oldenburg B. Exposure to Ambient Air Pollution and the Risk of Inflammatory Bowel Disease: A European Nested Case-Control Study. Dig Dis Sci 2016;61:2963-71. [PMID: 27461060 DOI: 10.1007/s10620-016-4249-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
48 Qi Y, Wu HM, Yang Z, Zhou YF, Jin L, Yang MF, Wang FY. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease. Dig Dis Sci 2021. [PMID: 33527328 DOI: 10.1007/s10620-021-06837-2] [Reference Citation Analysis]
49 Hornschuh M, Wirthgen E, Wolfien M, Singh KP, Wolkenhauer O, Däbritz J. The role of epigenetic modifications for the pathogenesis of Crohn's disease. Clin Epigenetics 2021;13:108. [PMID: 33980294 DOI: 10.1186/s13148-021-01089-3] [Reference Citation Analysis]
50 Mack DR. Probiotics in inflammatory bowel diseases and associated conditions. Nutrients. 2011;3:245-264. [PMID: 22254095 DOI: 10.3390/nu3020245] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
51 Feldman C, Anderson R. Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. J Infect 2013;67:169-84. [PMID: 23707875 DOI: 10.1016/j.jinf.2013.05.004] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 11.9] [Reference Citation Analysis]
52 Okabayashi S, Kobayashi T, Hibi T. Inflammatory Bowel Disease in Japan-Is It Similar to or Different from Westerns? J Anus Rectum Colon 2020;4:1-13. [PMID: 32002471 DOI: 10.23922/jarc.2019-003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
53 Raftery AL, Tsantikos E, Harris NL, Hibbs ML. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease. Front Immunol 2020;11:2144. [PMID: 33042125 DOI: 10.3389/fimmu.2020.02144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 2007;13:6134-9. [PMID: 18069751 DOI: 10.3748/wjg.v13.i46.6134] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 63] [Article Influence: 4.0] [Reference Citation Analysis]
55 Blonski W, Buchner AM, Lichtenstein GR. Clinical predictors of aggressive/disabling disease: ulcerative colitis and crohn disease. Gastroenterol Clin North Am. 2012;41:443-462. [PMID: 22500528 DOI: 10.1016/j.gtc.2012.01.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
56 Andersen V, Olsen A, Carbonnel F, Tjønneland A, Vogel U. Diet and risk of inflammatory bowel disease. Dig Liver Dis. 2012;44:185-194. [PMID: 22055893 DOI: 10.1016/j.dld.2011.10.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 61] [Article Influence: 7.9] [Reference Citation Analysis]
57 Takahashi H, Matsui T, Hisabe T, Hirai F, Takatsu N, Tsurumi K, Kanemitsu T, Sato Y, Kinjyo K, Yano Y, Takaki Y, Nagahama T, Yao K, Washio M. Second peak in the distribution of age at onset of ulcerative colitis in relation to smoking cessation. J Gastroenterol Hepatol. 2014;29:1603-1608. [PMID: 24731020 DOI: 10.1111/jgh.12616] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
58 Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65:100851. [PMID: 30837080 DOI: 10.1016/j.disamonth.2019.02.004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 25.0] [Reference Citation Analysis]
59 Chen YL, Hsu CW, Cheng CC, Yiang GT, Lin CS, Lin CL, Sung FC, Liang JA. Increased subsequent risk of inflammatory bowel disease association in patients with chronic pancreatitis: a nationwide population-based cohort study. Curr Med Res Opin 2017;33:1077-82. [PMID: 28277863 DOI: 10.1080/03007995.2017.1300143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
60 Galandiuk S. E-cigarettes: an asset or liability in efforts to lessen tobacco smoking and its consequences. Mayo Clin Proc 2015;90:1-3. [PMID: 25572189 DOI: 10.1016/j.mayocp.2014.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
61 Wallwork R, Perugino CA, Fu X, Harkness T, Zhang Y, Choi HK, Stone JH, Wallace ZS. The Association of Smoking with IgG4-Related Disease: A Case-Control Study. Rheumatology (Oxford) 2021:keab172. [PMID: 33751033 DOI: 10.1093/rheumatology/keab172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Moura FA, Goulart MOF. Inflammatory Bowel Diseases. Gastrointestinal Tissue. Elsevier; 2017. pp. 99-112. [DOI: 10.1016/b978-0-12-805377-5.00007-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Johannsen A, Susin C, Gustafsson A. Smoking and inflammation: evidence for a synergistic role in chronic disease. Periodontol 2000. 2014;64:111-126. [PMID: 24320959 DOI: 10.1111/j.1600-0757.2012.00456.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 87] [Article Influence: 16.8] [Reference Citation Analysis]
64 Helbig KL, Nothnagel M, Hampe J, Balschun T, Nikolaus S, Schreiber S, Franke A, Nöthlings U. A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn’s disease aetiology. BMC Med Genet. 2012;13:14. [PMID: 22416979 DOI: 10.1186/1471-2350-13-14] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
65 Rogers MA, Greene MT, Saint S, Chenoweth CE, Malani PN, Trivedi I, Aronoff DM. Higher rates of Clostridium difficile infection among smokers. PLoS One 2012;7:e42091. [PMID: 22848714 DOI: 10.1371/journal.pone.0042091] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
66 Owczarek D, Rodacki T, Domagała-Rodacka R, Cibor D, Mach T. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol 2016;22:895-905. [PMID: 26811635 DOI: 10.3748/wjg.v22.i3.895] [Cited by in CrossRef: 102] [Cited by in F6Publishing: 73] [Article Influence: 25.5] [Reference Citation Analysis]
67 Uchiyama K, Haruyama Y, Shiraishi H, Katahira K, Abukawa D, Ishige T, Tajiri H, Uchida K, Uchiyama K, Washio M, Kobashi E, Maekawa A, Okamoto K, Sairenchi T, Imamura Y, Ohhira S, Hata A, Kobashi G. Association between Passive Smoking from the Mother and Pediatric Crohn's Disease: A Japanese Multicenter Study. Int J Environ Res Public Health 2020;17:E2926. [PMID: 32340304 DOI: 10.3390/ijerph17082926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 O'Brien SJ, Hallion J, Scheurlen KM, Fiechter C, Burton J, Paas M, Schmidt M, Gardner S, Eichenberger MR, Pan J, Rai S, Galandiuk S. Crohn's disease-related single nucleotide polymorphisms are associated with ileal pouch afferent limb stenosis. J Gastrointest Surg 2021. [PMID: 33443688 DOI: 10.1007/s11605-020-04884-0] [Reference Citation Analysis]
69 Wada S, Sato K, Ohta R, Wada E, Bou Y, Fujiwara M, Kiyono T, Park EY, Aoi W, Takagi T, Naito Y, Yoshikawa T. Ingestion of Low Dose Pyroglutamyl Leucine Improves Dextran Sulfate Sodium-Induced Colitis and Intestinal Microbiota in Mice. J Agric Food Chem 2013;61:8807-13. [DOI: 10.1021/jf402515a] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
70 Stjernman H, Tysk C, Almer S, Ström M, Hjortswang H. Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease. Eur J Gastroenterol Hepatol 2011;23:671-9. [PMID: 21654323 DOI: 10.1097/MEG.0b013e328346f622] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
71 Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis. 2008;23:1213-1221. [PMID: 18762954 DOI: 10.1007/s00384-008-0542-9.] [Reference Citation Analysis]
72 Wang H, Zhao JX, Hu N, Ren J, Du M, Zhu MJ. Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins. World J Gastroenterol 2012;18:2180-7. [PMID: 22611310 DOI: 10.3748/wjg.v18.i18.2180] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 58] [Article Influence: 6.9] [Reference Citation Analysis]
73 Logan I, Bowlus CL. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev. 2010;9:A372-A378. [PMID: 19903540 DOI: 10.1016/j.autrev.2009.11.008] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 6.8] [Reference Citation Analysis]
74 Andersen V, Nimmo E, Krarup HB, Drummond H, Christensen J, Ho GT, Ostergaard M, Ernst A, Lees C, Jacobsen BA, Satsangi J, Vogel U. Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study. Inflamm Bowel Dis 2011;17:937-46. [PMID: 20803508 DOI: 10.1002/ibd.21440] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
75 Thomas T, Chandan JS, Li VSW, Lai CY, Tang W, Bhala N, Kaplan GG, Ng SC, Ghosh S. Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts. PLoS One 2019;14:e0221961. [PMID: 31545811 DOI: 10.1371/journal.pone.0221961] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
76 Yamamoto T, Nakahigashi M, Saniabadi AR. Review article: diet and inflammatory bowel disease--epidemiology and treatment. Aliment Pharmacol Ther. 2009;30:99-112. [PMID: 19438426 DOI: 10.1111/j.1365-2036.2009.04035.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
77 Leung WK, Ng SC, Chow DK, Lao WC, Leung VK, Li MK, Hui YT, Ng SS, Hui AJ, Lai ST. Use of biologics for inflammatory bowel disease in Hong Kong: consensus statement. Hong Kong Med J. 2013;19:61-68. [PMID: 23378357 DOI: 10.1007/s00535-012-0673-1] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 9.3] [Reference Citation Analysis]
78 Ko Y, Kariyawasam V, Karnib M, Butcher R, Samuel D, Alrubaie A, Rahme N, McDonald C, Cowlishaw J, Katelaris P, Barr G, Jones B, Connor S, Paven G, Chapman G, Park G, Gearry R, Leong RW; IBD Sydney Organisation. Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia. Clin Gastroenterol Hepatol 2015;13:1453-63.e1. [PMID: 25771246 DOI: 10.1016/j.cgh.2015.02.045] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
79 van der Sloot KWJ, Weersma RK, Dijkstra G, Alizadeh BZ. Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ). J Gastroenterol. 2019;54:238-248. [PMID: 30109418 DOI: 10.1007/s00535-018-1501-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
80 Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN. Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46:780-789. [PMID: 28892171 DOI: 10.1111/apt.14291] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 16.8] [Reference Citation Analysis]
81 Andersen AM, Lei MK, Beach SRH, Philibert RA. Inflammatory biomarker relationships with helper T cell GPR15 expression and cannabis and tobacco smoking. J Psychosom Res 2021;141:110326. [PMID: 33310155 DOI: 10.1016/j.jpsychores.2020.110326] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Nunes T, Fiorino G, Danese S, Sans M. Familial aggregation in inflammatory bowel disease: is it genes or environment? World J Gastroenterol. 2011;17:2715-2722. [PMID: 21734779 DOI: 10.3748/wjg.v17.i22.2715] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
83 Narula N, Wong ECL, Dehghan M, Mente A, Rangarajan S, Lanas F, Lopez-Jaramillo P, Rohatgi P, Lakshmi PVM, Varma RP, Orlandini A, Avezum A, Wielgosz A, Poirier P, Almadi MA, Altuntas Y, Ng KK, Chifamba J, Yeates K, Puoane T, Khatib R, Yusuf R, Boström KB, Zatonska K, Iqbal R, Weida L, Yibing Z, Sidong L, Dans A, Yusufali A, Mohammadifard N, Marshall JK, Moayyedi P, Reinisch W, Yusuf S. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ 2021;374:n1554. [PMID: 34261638 DOI: 10.1136/bmj.n1554] [Reference Citation Analysis]
84 Andersen V, Christensen J, Ernst A, Jacobsen BA, Tjønneland A, Krarup HB, Vogel U. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease. World J Gastroenterol. 2011;17:197-206. [PMID: 21245992 DOI: 10.3748/wjg.v17.i2.197] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
85 Widbom L, Schneede J, Midttun Ø, Ueland PM, Karling P, Hultdin J. Elevated plasma cotinine is associated with an increased risk of developing IBD, especially among users of combusted tobacco. PLoS One 2020;15:e0235536. [PMID: 32614903 DOI: 10.1371/journal.pone.0235536] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Hujoel PP, Kotsakis G, Hujoel IA. Dental Morbidities, Smoking, Oral Hygiene, and Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2016;14:1840-1. [DOI: 10.1016/j.cgh.2016.07.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
87 Domènech E, Carrión S, Garcia-Planella E, Mañosa M, Gordillo J, Concepción M, Guarner C, Cabré E. Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease. Inflamm Bowel Dis 2011;17:971-5. [PMID: 20824819 DOI: 10.1002/ibd.21456] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
88 Latella G, Papi C. Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol. 2012;18:3790-3799. [PMID: 22876029 DOI: 10.3748/wjg.v18.i29.3790] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 60] [Article Influence: 8.8] [Reference Citation Analysis]
89 Ananthakrishnan AN, Nguyen DD, Sauk J, Yajnik V, Xavier RJ. Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20:783-789. [PMID: 24651583 DOI: 10.1097/mib.0000000000000014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
90 Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol. 2016;22:6296-6317. [PMID: 27468219 DOI: 10.3748/wjg.v22.i27.6296] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 61] [Article Influence: 17.3] [Reference Citation Analysis]
91 Elhenawy W, Tsai CN, Coombes BK. Host-Specific Adaptive Diversification of Crohn's Disease-Associated Adherent-Invasive Escherichia coli. Cell Host Microbe. 2019;25:301-312.e5. [PMID: 30683582 DOI: 10.1016/j.chom.2018.12.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
92 Murakami Y, Nishiwaki Y, Oba MS, Asakura K, Ohfuji S, Fukushima W, Suzuki Y, Nakamura Y. Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2014: an analysis of a nationwide survey. J Gastroenterol 2019;54:1070-7. [PMID: 31309327 DOI: 10.1007/s00535-019-01603-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
93 Piovani D, Danese S, Peyrin-Biroulet L, Bonovas S. Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study. J Crohns Colitis 2020;14:323-31. [PMID: 31504350 DOI: 10.1093/ecco-jcc/jjz150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
94 Biedermann L, Fournier N, Misselwitz B, Frei P, Zeitz J, Manser CN, Pittet V, Juillerat P, von Känel R, Fried M, Vavricka SR, Rogler G; for the Swiss Inflammatory Bowel Disease Cohort Study Group. High Rates of Smoking Especially in Female Crohn’s Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation—Data from the Swiss IBD Cohort Study. ECCOJC 2015;9:819-29. [DOI: 10.1093/ecco-jcc/jjv113] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
95 Rosenfeld G, Bressler B. Editorial: The Truth About Cigarette Smoking and the Risk of Inflammatory Bowel Disease. American Journal of Gastroenterology 2012;107:1407-8. [DOI: 10.1038/ajg.2012.190] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
96 Jaruvongvanich V, Poonsombudlert K, Ungprasert P. Smoking and Risk of Microscopic Colitis: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2019;25:672-8. [PMID: 30869794 DOI: 10.1093/ibd/izy296] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
97 Piscaglia AC, Lopetuso LR, Laterza L, Gerardi V, Sacchini E, Leoncini E, Boccia S, Stefanelli ML, Gasbarrini A, Armuzzi A. Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study. Digestive and Liver Disease 2019;51:218-25. [DOI: 10.1016/j.dld.2018.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Lanier WL. Mayo Clinic Proceedings 2007: Enriching Our Service to Authors and Readers. Mayo Clinic Proceedings 2007;82:16-9. [DOI: 10.1016/s0025-6196(11)60962-2] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
99 Yang T, Zhang Y, Wei J, Zeng C, Li LJ, Xie X, Wang YL, Xie DX, Li H, Yang C, Lei GH. Relationship between cigarette smoking and hyperuricemia in middle-aged and elderly population: a cross-sectional study. Rheumatol Int 2017;37:131-6. [PMID: 27704161 DOI: 10.1007/s00296-016-3574-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
100 Sun Y, Zhang Z, Zheng CQ, Sang LX. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review. World J Gastroenterol 2021;27:2963-78. [PMID: 34168401 DOI: 10.3748/wjg.v27.i22.2963] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Kanaan ZM, Eichenberger MR, Ahmad S, Weller C, Roberts H, Pan J, Rai SN, Petras R, Weller EB Jr, Galandiuk S. Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population. J Negat Results Biomed 2012;11:7. [PMID: 22269043 DOI: 10.1186/1477-5751-11-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
102 Baron JA, Nichols HB, Anderson C, Safe S. Cigarette Smoking and Estrogen-Related Cancer. Cancer Epidemiol Biomarkers Prev 2021;30:1462-71. [PMID: 33990391 DOI: 10.1158/1055-9965.EPI-20-1803] [Reference Citation Analysis]
103 Duffin KC, Freeny IC, Schrodi SJ, Wong B, Feng BJ, Soltani-Arabshahi R, Rakkhit T, Goldgar DE, Krueger GG. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol 2009;129:2777-83. [PMID: 19554022 DOI: 10.1038/jid.2009.169] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
104 Vegh Z, Burisch J, Pedersen N, Kaimakliotis I, Duricova D, Bortlik M, Avnstrøm S, Vinding KK, Olsen J, Nielsen KR. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. J Crohns Colitis. 2014;8:1506-1515. [PMID: 24998983 DOI: 10.1016/j.crohns.2014.06.004] [Cited by in Crossref: 65] [Cited by in F6Publishing: 50] [Article Influence: 9.3] [Reference Citation Analysis]
105 Torres J, Burisch J, Riddle M, Dubinsky M, Colombel J. Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities. Gut 2016;65:1061-9. [DOI: 10.1136/gutjnl-2016-311785] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 7.6] [Reference Citation Analysis]
106 Aniwan S, Park SH, Loftus EV. Epidemiology, Natural History, and Risk Stratification of Crohn's Disease. Gastroenterology Clinics of North America 2017;46:463-80. [DOI: 10.1016/j.gtc.2017.05.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
107 Khasawneh M, Spence AD, Addley J, Allen PB. The role of smoking and alcohol behaviour in the management of inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2017;31:553-559. [PMID: 29195675 DOI: 10.1016/j.bpg.2017.10.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
108 Chervy M, Barnich N, Denizot J. Adherent-Invasive E. coli: Update on the Lifestyle of a Troublemaker in Crohn's Disease. Int J Mol Sci 2020;21:E3734. [PMID: 32466328 DOI: 10.3390/ijms21103734] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
109 Mahid SS, Mulhall AM, Gholson RD, Eichenberger MR, Galandiuk S. Inflammatory bowel disease and African Americans: a systematic review. Inflamm Bowel Dis 2008;14:960-7. [PMID: 18266229 DOI: 10.1002/ibd.20389] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
110 Andersen AM, Lei MK, Beach SRH, Philibert RA, Sinha S, Colgan JD. Cigarette and Cannabis Smoking Effects on GPR15+ Helper T Cell Levels in Peripheral Blood: Relationships with Epigenetic Biomarkers. Genes (Basel) 2020;11:E149. [PMID: 32019074 DOI: 10.3390/genes11020149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
111 Low D, Nguyen DD, Mizoguchi E. Animal models of ulcerative colitis and their application in drug research. Drug Des Devel Ther. 2013;7:1341-1357. [PMID: 24250223 DOI: 10.2147/dddt.s40107] [Cited by in Crossref: 34] [Cited by in F6Publishing: 61] [Article Influence: 4.3] [Reference Citation Analysis]
112 Poudel DR, Karmacharya P, Donato A. Risk of acute gout among active smokers: data from nationwide inpatient sample. Clin Rheumatol 2016;35:3015-8. [PMID: 27658418 DOI: 10.1007/s10067-016-3415-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
113 Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756-1770. [PMID: 27914657 DOI: 10.1016/s0140-6736(16)32126-2] [Cited by in Crossref: 830] [Cited by in F6Publishing: 325] [Article Influence: 166.0] [Reference Citation Analysis]
114 John RA, Gearry RB. Smoking Cessation for Patients With Crohn Disease: Not Just for the Patient? Inflamm Bowel Dis 2021;27:386-7. [PMID: 32529237 DOI: 10.1093/ibd/izaa118] [Reference Citation Analysis]
115 Hlavaty T, Toth J, Koller T, Krajcovicova A, Oravcova S, Zelinkova Z, Huorka M. Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case-control study. United European Gastroenterol J. 2013;1:109-119. [PMID: 24917948 DOI: 10.1177/2050640613478011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
116 Napier MD, Poole C, Satten GA, Ashley-Koch A, Marrie RA, Williamson DM. Heavy metals, organic solvents, and multiple sclerosis: An exploratory look at gene-environment interactions. Arch Environ Occup Health 2016;71:26-34. [PMID: 25137520 DOI: 10.1080/19338244.2014.937381] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
117 Guo Z, Wu R, Zhu W, Gong J, Zhang W, Li Y, Gu L, Li N, Li J. Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn’s disease. Nutr Clin Pract. 2013;28:499-505. [PMID: 23851180 DOI: 10.1177/0884533613487218] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
118 El-Tawil AM. Smoking and inflammatory bowel diseases: what in smoking alters the course? Int J Colorectal Dis. 2010;25:671-680. [PMID: 20333390 DOI: 10.1007/s00384-010-0925-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
119 Vatn MH, Sandvik AK. Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2015;50:748-62. [DOI: 10.3109/00365521.2015.1033000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
120 Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol. 2008;6:41-45. [PMID: 18063423 DOI: 10.1016/j.cgh.2007.09.016] [Cited by in Crossref: 147] [Cited by in F6Publishing: 129] [Article Influence: 10.5] [Reference Citation Analysis]
121 Underner M, Perriot J, Cosnes J, Beau P, Peiffer G, Meurice J. Tabagisme, sevrage tabagique et maladie de Crohn. La Presse Médicale 2016;45:390-402. [DOI: 10.1016/j.lpm.2016.02.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Sicilia B, Arribas F, Nerín J, López Miguel C, Vicente R, Gomollón F. Risk factors for ulcerative colitis: A population-based, case-control study in Spain. J Crohns Colitis 2008;2:158-61. [PMID: 21172206 DOI: 10.1016/j.crohns.2008.01.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
123 Liu YF, Dong H, Chen Z, Wang YU, Tu SH. Impact of ankylosing spondylitis on sexual function: A systematic review and meta-analysis. Exp Ther Med 2015;9:1501-7. [PMID: 25780459 DOI: 10.3892/etm.2015.2239] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
124 Coletta M, Zefelippo A, Mazza S, D’abrosca V, Botti F, Oreggia B, Prati M, Boni L, Vecchi M, Caprioli F. Previous colonic resection is a risk factor for surgical relapse in Crohn’s disease. Digestive and Liver Disease 2019;51:206-11. [DOI: 10.1016/j.dld.2018.07.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Nunes T, Etchevers MJ, Domènech E, García-sánchez V, Ber Y, Peñalva M, Merino O, Nos P, Garcia-planella E, Casbas AG, Esteve M, Taxonera Samsó C, Montoro Huguet M, Gisbert JP, Martín Arranz MD, García-sepulcre MF, de Acosta MB, Beltrán B, Alcaide Suárez N, Saro Gismera C, Cabriada JL, Cañas-ventura A, Gomollón F, Panés J; Tobacco-Eneida Study Group of GETECCU. Smoking does influence disease behaviour and impacts the need for therapy in Crohn′s disease in the biologic era. Aliment Pharmacol Ther 2013;38:752-60. [DOI: 10.1111/apt.12440] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 6.6] [Reference Citation Analysis]
126 Chivese T, Esterhuizen TM, Basson AR, Watermeyer G. The Influence of Second-Hand Cigarette Smoke Exposure during Childhood and Active Cigarette Smoking on Crohn's Disease Phenotype Defined by the Montreal Classification Scheme in a Western Cape Population, South Africa. PLoS One 2015;10:e0139597. [PMID: 26422615 DOI: 10.1371/journal.pone.0139597] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
127 Barnes EL, Beery RM, Schulman AR, McCarthy EP, Korzenik JR, Winter RW. Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database. Inflamm Bowel Dis. 2016;22:2229-2237. [PMID: 27542135 DOI: 10.1097/mib.0000000000000899] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 7.7] [Reference Citation Analysis]
128 van der Sloot KWJ, Weersma RK, Alizadeh BZ, Dijkstra G. Identification of environmental risk factors associated with the development of Inflammatory Bowel Disease. J Crohns Colitis 2020:jjaa114. [PMID: 32572465 DOI: 10.1093/ecco-jcc/jjaa114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
129 Bennike TB, Carlsen TG, Ellingsen T, Bonderup OK, Glerup H, Bøgsted M, Christiansen G, Birkelund S, Stensballe A, Andersen V. Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies. Inflamm Bowel Dis. 2015;21:2052-2067. [PMID: 25993694 DOI: 10.1097/mib.0000000000000460] [Cited by in Crossref: 74] [Cited by in F6Publishing: 30] [Article Influence: 14.8] [Reference Citation Analysis]
130 Mendall MA, Jensen CB, Sørensen TIA, Ängquist LH, Jess T. Body mass index in young men and risk of inflammatory bowel disease through adult life: A population-based Danish cohort study. Sci Rep 2019;9:6360. [PMID: 31015530 DOI: 10.1038/s41598-019-42642-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
131 Wark G, Samocha-Bonet D, Ghaly S, Danta M. The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review. Nutrients 2020;13:E135. [PMID: 33396537 DOI: 10.3390/nu13010135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
132 Ng SC, Benjamin JL, McCarthy NE, Hedin CR, Koutsoumpas A, Plamondon S, Price CL, Hart AL, Kamm MA, Forbes A, Knight SC, Lindsay JO, Whelan K, Stagg AJ. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease. Inflamm Bowel Dis. 2011;17:2027-2037. [PMID: 21910165 DOI: 10.1002/ibd.21590] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
133 Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM. Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intest Res 2017;15:285-310. [PMID: 28670226 DOI: 10.5217/ir.2017.15.3.285] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
134 Laing B, Barnett MPG, Marlow G, Nasef NA, Ferguson LR. An update on the role of gut microbiota in chronic inflammatory diseases, and potential therapeutic targets. Expert Rev Gastroenterol Hepatol. 2018;12:969-983. [PMID: 30052094 DOI: 10.1080/17474124.2018.1505497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
135 Yashiro M. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease. Dig Dis Sci. 2015;60:2251-2263. [PMID: 25840920 DOI: 10.1007/s10620-015-3646-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
136 Gentile N, Yen EF. Prevalence, Pathogenesis, Diagnosis, and Management of Microscopic Colitis. Gut Liver 2018;12:227-35. [PMID: 28669150 DOI: 10.5009/gnl17061] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
137 Bennike T, Birkelund S, Stensballe A, Andersen V. Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies. World J Gastroenterol. 2014;20:3231-3244. [PMID: 24696607 DOI: 10.3748/wjg.v20.i12.3231] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 60] [Article Influence: 11.5] [Reference Citation Analysis]
138 Elten M, Benchimol EI, Fell DB, Kuenzig ME, Smith G, Kaplan GG, Chen H, Crouse D, Lavigne E. Residential Greenspace in Childhood Reduces Risk of Pediatric Inflammatory Bowel Disease: A Population-Based Cohort Study. Am J Gastroenterol 2021;116:347-53. [PMID: 33038129 DOI: 10.14309/ajg.0000000000000990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
139 Steiger C, Uchiyama K, Takagi T, Mizushima K, Higashimura Y, Gutmann M, Hermann C, Botov S, Schmalz HG, Naito Y, Meinel L. Prevention of colitis by controlled oral drug delivery of carbon monoxide. J Control Release 2016;239:128-36. [PMID: 27578097 DOI: 10.1016/j.jconrel.2016.08.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
140 Lu Y, Zamora-Ros R, Chan S, Cross AJ, Ward H, Jakszyn P, Luben R, Opstelten JL, Oldenburg B, Hallmans G, Karling P, Grip O, Key T, Bergmann MM, Boeing H, Overvad K, Palli D, Masala G, Khaw KT, Racine A, Carbonnel F, Boutron-Ruault MC, Andersen V, Olsen A, Tjonneland A, Kaaks R, Tumino R, Trichopoulou A, Scalbert A, Riboli E, Hart AR. Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC). Inflamm Bowel Dis 2017;23:2072-82. [PMID: 28837515 DOI: 10.1097/MIB.0000000000001108] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
141 Park HJ, Jung ES, Kong KA, Park EM, Cheon JH, Choi JH. Identification of OCTN2 variants and their association with phenotypes of Crohn's disease in a Korean population. Sci Rep 2016;6:22887. [PMID: 26965072 DOI: 10.1038/srep22887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
142 Lakatos PL, Vegh Z, Lovasz BD, David G, Pandur T, Erdelyi Z, Szita I, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics PA, Mandel M, Horvath A, Szathmari M, Kiss LS, Lakatos L. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflamm Bowel Dis 2013;19:1010-7. [PMID: 23399739 DOI: 10.1097/MIB.0b013e3182802b3e] [Cited by in Crossref: 53] [Cited by in F6Publishing: 23] [Article Influence: 6.6] [Reference Citation Analysis]
143 Lee J, Jee SR, Kim HW, Baek DH, Song GA, Moon W, Park SJ, Kim HJ, Lee JH, Park JH, Kim TO; Busan Ulsan Gyeongnam Intestinal Study Group Society (BIGS). Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis. PLoS One 2019;14:e0214129. [PMID: 30901362 DOI: 10.1371/journal.pone.0214129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
144 Johannsen A, Fored MC, Håkansson J, Ekbom A, Gustafsson A. Consumption of dental treatment in patients with inflammatory bowel disease, a register study. PLoS One 2015;10:e0134001. [PMID: 26267797 DOI: 10.1371/journal.pone.0134001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
145 Ueno A, Jijon H, Traves S, Chan R, Ford K, Beck PL, Iacucci M, Fort Gasia M, Barkema HW, Panaccione R, Kaplan GG, Proud D, Ghosh S. Opposing effects of smoking in ulcerative colitis and Crohn's disease may be explained by differential effects on dendritic cells. Inflamm Bowel Dis 2014;20:800-10. [PMID: 24691114 DOI: 10.1097/MIB.0000000000000018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
146 Haque SZ, Haque M. The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal. Clin Exp Gastroenterol 2017;10:91-103. [PMID: 28503071 DOI: 10.2147/CEG.S126243] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
147 Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther. 2016;7:112-125. [PMID: 26855817 DOI: 10.4292/wjgpt.v7.i1.112] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
148 Cushing K, Higgins PDR. Management of Crohn Disease: A Review. JAMA 2021;325:69-80. [PMID: 33399844 DOI: 10.1001/jama.2020.18936] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
149 Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 2007;13:6134-9. [PMID: 18069751 DOI: 10.3748/wjg.v13.i46.6134] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
150 Labarca G, Drake L, Horta G, Jantz MA, Mehta HJ, Fernandez-Bussy S, Folch E, Majid A, Picco M. Association between inflammatory bowel disease and chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Pulm Med 2019;19:186. [PMID: 31660921 DOI: 10.1186/s12890-019-0963-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
151 Hsu TY, Shih HM, Wang YC, Lin LC, He GY, Chen CY, Kao CH, Chen CH, Chen WK, Yang TY. Effect of Alcoholic Intoxication on the Risk of Inflammatory Bowel Disease: A Nationwide Retrospective Cohort Study. PLoS One 2016;11:e0165411. [PMID: 27802288 DOI: 10.1371/journal.pone.0165411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
152 Hutfless S, Fireman B, Kane S, Herrinton LJ. Screening differences and risk of cervical cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2008;28:598-605. [PMID: 18549465 DOI: 10.1111/j.1365-2036.2008.03766.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
153 Basson A. Vitamin D and Crohn's disease in the adult patient: a review. JPEN J Parenter Enteral Nutr 2014;38:438-58. [PMID: 24154811 DOI: 10.1177/0148607113506013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
154 Scaldaferri F, Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis. 2007;8:171-178. [PMID: 17970872 DOI: doi:10.1111/j.1751-2980.2007.00310.x] [Reference Citation Analysis]
155 Chen K, Pociask DA, McAleer JP, Chan YR, Alcorn JF, Kreindler JL, Keyser MR, Shapiro SD, Houghton AM, Kolls JK, Zheng M. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One 2011;6:e20333. [PMID: 21647421 DOI: 10.1371/journal.pone.0020333] [Cited by in Crossref: 107] [Cited by in F6Publishing: 111] [Article Influence: 10.7] [Reference Citation Analysis]
156 Kappelman MD, Farkas DK, Long MD, Erichsen R, Sandler RS, Sørensen HT, Baron JA. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12:265-73.e1. [PMID: 23602821 DOI: 10.1016/j.cgh.2013.03.034] [Cited by in Crossref: 112] [Cited by in F6Publishing: 95] [Article Influence: 14.0] [Reference Citation Analysis]
157 Ng SC, Woodrow S, Patel N, Subhani J, Harbord M. Role of genetic and environmental factors in British twins with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:725-736. [PMID: 21557397 DOI: 10.1002/ibd.21747] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
158 Porter CK, Tribble DR, Aliaga PA, Halvorson HA, Riddle MS. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology. 2008;135:781-786. [PMID: 18640117 DOI: 10.1053/j.gastro.2008.05.081] [Cited by in Crossref: 119] [Cited by in F6Publishing: 96] [Article Influence: 9.2] [Reference Citation Analysis]
159 Molodecky NA, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:1792-1799. [PMID: 21744435 DOI: 10.1002/ibd.21511] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
160 Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, Kato J, Kobayashi K, Kobayashi K, Koganei K, Kunisaki R, Motoya S, Nagahori M, Nakase H, Omata F, Saruta M, Watanabe T, Tanaka T, Kanai T, Noguchi Y, Takahashi KI, Watanabe K, Hibi T, Suzuki Y, Watanabe M, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018;53:305-353. [PMID: 29429045 DOI: 10.1007/s00535-018-1439-1] [Cited by in Crossref: 184] [Cited by in F6Publishing: 147] [Article Influence: 61.3] [Reference Citation Analysis]
161 Aldhous MC, Satsangi J. The impact of smoking in Crohn's disease: no smoke without fire. Frontline Gastroenterol 2010;1:156-64. [PMID: 28839569 DOI: 10.1136/fg.2010.001487] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
162 DeClercq V, Langille MGI, Van Limbergen J. Differences in adiposity and diet quality among individuals with inflammatory bowel disease in Eastern Canada. PLoS One 2018;13:e0200580. [PMID: 30024912 DOI: 10.1371/journal.pone.0200580] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
163 Coppell KJ, Galts CP, Huizing FY, Norton JK, Gray AR, Schultz K, Hobbs CE, Aluzaite K, Schultz M. Annual Incidence and Phenotypic Presentation of IBD in Southern New Zealand: An 18-Year Epidemiological Analysis. Inflamm Intest Dis 2018;3:32-9. [PMID: 30505840 DOI: 10.1159/000492615] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
164 Lucafò M, Franca R, Selvestrel D, Curci D, Pugnetti L, Decorti G, Stocco G. Pharmacogenetics of treatments for inflammatory bowel disease. Expert Opin Drug Metab Toxicol 2018;14:1209-23. [PMID: 30465611 DOI: 10.1080/17425255.2018.1551876] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
165 Liang H, Yang M, Zeng C, Wu W, Zhao L, Wang Y. Perfluorooctane sulfonate exerts inflammatory bowel disease-like intestinal injury in rats. PeerJ 2021;9:e10644. [PMID: 33510972 DOI: 10.7717/peerj.10644] [Reference Citation Analysis]
166 Franca R, Curci D, Lucafò M, Decorti G, Stocco G. Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease. Expert Opin Drug Metab Toxicol 2019;15:527-39. [PMID: 31177858 DOI: 10.1080/17425255.2019.1630378] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
167 Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses. Gastroenterology. 2019;157:647-659.e4. [PMID: 31014995 DOI: 10.1053/j.gastro.2019.04.016] [Cited by in Crossref: 103] [Cited by in F6Publishing: 86] [Article Influence: 51.5] [Reference Citation Analysis]
168 Taylor KM, Hanscombe KB, Prescott NJ, Iniesta R, Traylor M, Taylor NS, Fong S, Powell N, Irving PM, Anderson SH, Mathew CG, Lewis CM, Sanderson JD. Genetic and Inflammatory Biomarkers Classify Small Intestine Inflammation in Asymptomatic First-degree Relatives of Patients With Crohn's Disease. Clin Gastroenterol Hepatol 2020;18:908-916.e13. [PMID: 31202982 DOI: 10.1016/j.cgh.2019.05.061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
169 Steiger C, Hermann C, Meinel L. Localized delivery of carbon monoxide. Eur J Pharm Biopharm 2017;118:3-12. [PMID: 27836646 DOI: 10.1016/j.ejpb.2016.11.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
170 Wang W, Krishnan E. Cigarette smoking is associated with a reduction in the risk of incident gout: results from the Framingham Heart Study original cohort. Rheumatology (Oxford) 2015;54:91-5. [PMID: 25086327 DOI: 10.1093/rheumatology/keu304] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
171 Fernández A, Hernández V, Martínez-Ares D, Sanromán L, de Castro ML, Pineda JR, Carmona A, González-Portela C, Salgado C, Martínez-Cadilla J, Pereira S, García-Burriel JI, Vázquez S, Rodríguez-Prada I; EpiCom Group. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study. Gastroenterol Hepatol 2015;38:534-40. [PMID: 25890448 DOI: 10.1016/j.gastrohep.2015.03.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
172 Wang MH, Fiocchi C, Zhu X, Ripke S, Kamboh MI, Rebert N, Duerr RH, Achkar JP. Gene-gene and gene-environment interactions in ulcerative colitis. Hum Genet. 2014;133:547-558. [PMID: 24241240 DOI: 10.1007/s00439-013-1395-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
173 Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380:1606-1619. [PMID: 22914296 DOI: 10.1016/s0140-6736(12)60150-0] [Cited by in Crossref: 840] [Cited by in F6Publishing: 371] [Article Influence: 93.3] [Reference Citation Analysis]
174 Wu XR, Liu XL, Katz S, Shen B. Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis. Inflamm Bowel Dis. 2015;21:703-715. [PMID: 25687266 DOI: 10.1097/mib.0000000000000227] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
175 Regeling A, Imhann F, Volders HH, Blokzijl T, Bloks VW, Weersma RK, Dijkstra G, Faber KN. HSPA6 is an ulcerative colitis susceptibility factor that is induced by cigarette smoke and protects intestinal epithelial cells by stabilizing anti-apoptotic Bcl-XL. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2016;1862:788-96. [DOI: 10.1016/j.bbadis.2016.01.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
176 Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012;107:1399-1406. [PMID: 22777340 DOI: 10.1038/ajg.2012.196] [Cited by in Crossref: 120] [Cited by in F6Publishing: 109] [Article Influence: 13.3] [Reference Citation Analysis]
177 Manolakis AC, Kapsoritakis AN, Georgoulias P, Tzavara C, Valotassiou V, Kapsoritaki A, Potamianos SP. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome. BMC Gastroenterol. 2010;10:118. [PMID: 20946669 DOI: 10.1186/1471-230x-10-118] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
178 Syal G, Serrano M, Jain A, Cohen BL, Rieder F, Stone C, Abraham B, Hudesman D, Malter L, McCabe R, Holubar S, Afzali A, Cheifetz AS, Gaidos JKJ, Moss AC. Health Maintenance Consensus for Adults With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izab155. [PMID: 34279600 DOI: 10.1093/ibd/izab155] [Reference Citation Analysis]
179 Harris KG, Chang EB. The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease. Clin Sci (Lond) 2018;132:2013-28. [PMID: 30232239 DOI: 10.1042/CS20171110] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
180 Salih A, Widbom L, Hultdin J, Karling P. Smoking is associated with risk for developing inflammatory bowel disease including late onset ulcerative colitis: a prospective study. Scand J Gastroenterol. 2018;53:173-178. [PMID: 29262738 DOI: 10.1080/00365521.2017.1418904] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
181 Liu R, Vaishnav RA, Roberts AM, Friedland RP. Humans have antibodies against a plant virus: evidence from tobacco mosaic virus. PLoS One 2013;8:e60621. [PMID: 23573274 DOI: 10.1371/journal.pone.0060621] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
182 Llaó J, Naves JE, Ruiz-Cerulla A, Gordillo J, Mañosa M, Maisterra S, Cabré E, Garcia-Planella E, Guardiola J, Domènech E. Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies. Dig Liver Dis 2016;48:608-12. [PMID: 27012443 DOI: 10.1016/j.dld.2016.02.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
183 Shrestha MP, Taleban S. Management of Ulcerative Colitis in the Elderly. Drugs Aging 2019;36:13-27. [DOI: 10.1007/s40266-018-0611-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
184 Nunes T, Etchevers MJ, García-Sánchez V, Ginard D, Martí E, Barreiro-de Acosta M, Gomollón F, Arroyo M, Bastida G, Gonzalez B. Impact of Smoking Cessation on the Clinical Course of Crohn’s Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study. Am J Gastroenterol. 2016;111:411-419. [PMID: 26856753 DOI: 10.1038/ajg.2015.401] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 8.2] [Reference Citation Analysis]
185 Grover S, Dougan M, Tyan K, Giobbie-Hurder A, Blum SM, Ishizuka J, Qazi T, Elias R, Vora KB, Ruan AB, Martin-Doyle W, Manos M, Eastman L, Davis M, Gargano M, Haq R, Buchbinder EI, Sullivan RJ, Ott PA, Hodi FS, Rahma OE. Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis. Cancer. 2020;126:3758-3767. [PMID: 32567084 DOI: 10.1002/cncr.32966] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
186 Ng SC, Tang W, Leong RW, Chen M, Ko Y, Studd C, Niewiadomski O, Bell S, Kamm MA, de Silva HJ, Kasturiratne A, Senanayake YU, Ooi CJ, Ling KL, Ong D, Goh KL, Hilmi I, Ouyang Q, Wang YF, Hu P, Zhu Z, Zeng Z, Wu K, Wang X, Xia B, Li J, Pisespongsa P, Manatsathit S, Aniwan S, Simadibrata M, Abdullah M, Tsang SW, Wong TC, Hui AJ, Chow CM, Yu HH, Li MF, Ng KK, Ching J, Wu JC, Chan FK, Sung JJ; Asia-Pacific Crohn's and Colitis Epidemiology Study ACCESS Group. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64:1063-1071. [PMID: 25217388 DOI: 10.1136/gutjnl-2014-307410] [Cited by in Crossref: 179] [Cited by in F6Publishing: 161] [Article Influence: 25.6] [Reference Citation Analysis]
187 Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am 2020;49:643-54. [PMID: 33121686 DOI: 10.1016/j.gtc.2020.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
188 Bastida G, Beltrán B. Ulcerative colitis in smokers, non-smokers and ex-smokers. World J Gastroenterol 2011;17:2740-7. [PMID: 21734782 DOI: 10.3748/wjg.v17.i22.2740] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
189 AlQasrawi D, Qasem A, Naser SA. Divergent Effect of Cigarette Smoke on Innate Immunity in Inflammatory Bowel Disease: A Nicotine-Infection Interaction. Int J Mol Sci 2020;21:E5801. [PMID: 32823518 DOI: 10.3390/ijms21165801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
190 Magyari L, Bene J, Komlósi K, Talián G, Faragó B, Csöngei V, Járomi L, Sáfrány E, Sipeky C, Lakner L, Varga M, Gasztonyi B, Melegh B. Prevalence of SLC22A4 1672T and SLC22A5 −207C combination defined TC haplotype in Hungarian ulcerative colitis patients. Pathol Oncol Res 2007;13:53-6. [DOI: 10.1007/bf02893441] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
191 King D, Rees J, Mytton J, Harvey P, Thomas T, Cooney R, Patel P, Trudgill N. The Outcomes of Emergency Admissions With Ulcerative Colitis Between 2007 and 2017 in England. J Crohns Colitis 2020;14:764-72. [PMID: 31714573 DOI: 10.1093/ecco-jcc/jjz185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
192 Fuller-thomson E, West KJ, Sulman J, Baird SL. Childhood Maltreatment Is Associated with Ulcerative Colitis but Not Crohnʼs Disease: Findings from a Population-based Study. Inflammatory Bowel Diseases 2015;21:2640-8. [DOI: 10.1097/mib.0000000000000551] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
193 Blackwell J, Saxena S, Alexakis C, Bottle A, Cecil E, Majeed A, Pollok RC. The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population-based study. Aliment Pharmacol Ther. 2019;50:556-567. [PMID: 31389044 DOI: 10.1111/apt.15390] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
194 Low D, Nguyen DD, Mizoguchi E. Animal models of ulcerative colitis and their application in drug research. Drug Des Devel Ther. 2013;7:1341-1357. [PMID: 24250223 DOI: 10.2147/DDDT.S40107.eCollection] [Reference Citation Analysis]
195 Inamdar S, Volfson A, Rosen L, Sunday S, Katz S, Sultan K. Smoking and Early Infliximab Response in Crohn's Disease: a Meta-analysis. Journal of Crohn's and Colitis 2015;9:140-6. [DOI: 10.1093/ecco-jcc/jju018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
196 Bringiotti R, Ierardi E, Lovero R, Losurdo G, Di Leo A, Principi M. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World J Gastrointest Pathophysiol 2014;5:550-9. [PMID: 25400998 DOI: 10.4291/wjgp.v5.i4.550] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
197 Lin HC, Chiu CC, Chen SF, Lou HY, Chiu WT, Chen YH. Ulcerative colitis and pregnancy outcomes in an Asian population. Am J Gastroenterol. 2010;105:387-394. [PMID: 19809415 DOI: 10.1038/ajg.2009.562] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
198 Lee HS, Park SH, Yang SK, Kim SO, Soh JS, Lee S, Bae JH, Lee HJ, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH. Appendectomy and the clinical course of ulcerative colitis: a retrospective cohort study and a nested case-control study from Korea. J Gastroenterol Hepatol 2015;30:470-7. [PMID: 25159898 DOI: 10.1111/jgh.12707] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
199 Ikeda A, Mizushima T, Egashira Y, Takahashi H, Miyoshi N, Haraguchi N, Hata T, Matsuda C, Doki Y, Mori M. Diverticular colitis with progression to ulcerative colitis after sigmoidectomy. Clin J Gastroenterol 2018;11:42-7. [DOI: 10.1007/s12328-017-0801-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
200 Kiernan MG, Coffey JC, Sahebally SM, Tibbitts P, Lyons EM, O'leary E, Owolabi F, Dunne CP. Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy. J Crohns Colitis 2020;14:118-29. [PMID: 31241755 DOI: 10.1093/ecco-jcc/jjz117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
201 Ohfuji S, Fukushima W, Watanabe K, Sasaki S, Yamagami H, Nagahori M, Watanabe M, Hirota Y; Japanese Case-Control Study Group for Ulcerative Colitis. Pre-illness isoflavone consumption and disease risk of ulcerative colitis: a multicenter case-control study in Japan. PLoS One. 2014;9:e110270. [PMID: 25314032 DOI: 10.1371/journal.pone.0110270] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
202 Biedermann L, Rogler G. Environmental factors and their impact on the intestinal microbiota: a role for human disease? Dig Dis 2012;30 Suppl 3:20-7. [PMID: 23295688 DOI: 10.1159/000342590] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
203 Bernstein CN. Review article: changes in the epidemiology of inflammatory bowel disease-clues for aetiology. Aliment Pharmacol Ther 2017;46:911-9. [PMID: 28949021 DOI: 10.1111/apt.14338] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
204 Oligschlaeger Y, Yadati T, Houben T, Condello Oliván CM, Shiri-Sverdlov R. Inflammatory Bowel Disease: A Stressed "Gut/Feeling". Cells 2019;8:E659. [PMID: 31262067 DOI: 10.3390/cells8070659] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
205 Alvarez-Lobos M, Pizarro DP, Palavecino CE, Espinoza A, Sebastián VP, Alvarado JC, Ibañez P, Quintana C, Díaz O, Kalergis AM, Bueno SM. Role of Salmonella enterica exposure in Chilean Crohn's disease patients. World J Gastroenterol 2013;19:5855-62. [PMID: 24124330 DOI: 10.3748/wjg.v19.i35.5855] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
206 Berkowitz L, Schultz BM, Salazar GA, Pardo-Roa C, Sebastián VP, Álvarez-Lobos MM, Bueno SM. Impact of Cigarette Smoking on the Gastrointestinal Tract Inflammation: Opposing Effects in Crohn's Disease and Ulcerative Colitis. Front Immunol 2018;9:74. [PMID: 29441064 DOI: 10.3389/fimmu.2018.00074] [Cited by in Crossref: 58] [Cited by in F6Publishing: 36] [Article Influence: 19.3] [Reference Citation Analysis]
207 Jones DT, Osterman MT, Bewtra M, Lewis JD. Passive smoking and inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008;103:2382-93. [PMID: 18844625 DOI: 10.1111/j.1572-0241.2008.01999.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
208 Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Richter JM, Nimptsch K, Wu K, Chan AT. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis 2015;21:2311-9. [PMID: 26236952 DOI: 10.1097/MIB.0000000000000501] [Cited by in Crossref: 10] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
209 Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79. [PMID: 23013615 DOI: 10.1186/gb-2012-13-9-r79] [Cited by in Crossref: 1478] [Cited by in F6Publishing: 1299] [Article Influence: 164.2] [Reference Citation Analysis]
210 Conley S, Proctor DD, Jeon S, Sandler RS, Redeker NS. Symptom clusters in adults with inflammatory bowel disease. Res Nurs Health 2017;40:424-34. [PMID: 28833284 DOI: 10.1002/nur.21813] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
211 Feuerstein JD, Cheifetz AS. Crohn Disease: Epidemiology, Diagnosis, and Management. Mayo Clin Proc. 2017;92:1088-1103. [PMID: 28601423 DOI: 10.1016/j.mayocp.2017.04.010] [Cited by in Crossref: 111] [Cited by in F6Publishing: 77] [Article Influence: 27.8] [Reference Citation Analysis]
212 Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Prescott NJ, Pessoa-Lopes P, Mathew CG, Sanderson J, Hart AL. Smokers with active Crohn’s disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis. 2012;18:1092-1100. [PMID: 22102318 DOI: 10.1002/ibd.21864] [Cited by in Crossref: 118] [Cited by in F6Publishing: 111] [Article Influence: 11.8] [Reference Citation Analysis]
213 Feuerstein JD, Cheifetz AS. Ulcerative colitis: epidemiology, diagnosis, and management. Mayo Clin Proc. 2014;89:1553-1563. [PMID: 25199861 DOI: 10.1016/j.mayocp.2014.07.002] [Cited by in Crossref: 127] [Cited by in F6Publishing: 93] [Article Influence: 18.1] [Reference Citation Analysis]
214 Uniken Venema WT, Voskuil MD, Dijkstra G, Weersma RK, Festen EA. The genetic background of inflammatory bowel disease: from correlation to causality. J Pathol. 2017;241:146-158. [PMID: 27785786 DOI: 10.1002/path.4817] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 11.0] [Reference Citation Analysis]
215 Sze MA, Hogg JC, Sin DD. Bacterial microbiome of lungs in COPD. Int J Chron Obstruct Pulmon Dis 2014;9:229-38. [PMID: 24591822 DOI: 10.2147/COPD.S38932] [Cited by in Crossref: 18] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
216 Carlens C, Hergens MP, Grunewald J, Ekbom A, Eklund A, Höglund CO, Askling J. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med. 2010;181:1217-1222. [PMID: 20203245 DOI: 10.1164/rccm.200909-1338oc] [Cited by in Crossref: 113] [Cited by in F6Publishing: 47] [Article Influence: 10.3] [Reference Citation Analysis]
217 Timm S, Svanes C, Janson C, Sigsgaard T, Johannessen A, Gislason T, Jogi R, Omenaas E, Forsberg B, Torén K. Place of upbringing in early childhood as related to inflammatory bowel diseases in adulthood: a population-based cohort study in Northern Europe. Eur J Epidemiol. 2014;29:429-437. [PMID: 24916994 DOI: 10.1007/s10654-014-9922-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
218 Qin Z, Wan JJ, Sun Y, Wu T, Wang PY, Du P, Su DF, Yang Y, Liu X. Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3. J Mol Med (Berl) 2017;95:221-33. [PMID: 27709266 DOI: 10.1007/s00109-016-1473-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
219 Andersen V, Holmskov U, Sørensen SB, Jawhara M, Andersen KW, Bygum A, Hvid L, Grauslund J, Wied J, Glerup H, Fredberg U, Villadsen JA, Kjær SG, Fallingborg J, Moghadd SAGR, Knudsen T, Brodersen J, Frøjk J, Dahlerup JF, Nielsen OH, Christensen R, Bojesen AB, Sorensen GL, Thiel S, Færgeman NJ, Brandslund I, Stensballe A, Schmidt EB, Franke A, Ellinghaus D, Rosenstiel P, Raes J, Heitmann B, Boye M, Nielsen CL, Werner L, Kjeldsen J, Ellingsen T. A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine. Nutrients 2017;9:E499. [PMID: 28505128 DOI: 10.3390/nu9050499] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
220 Xu Y, Li Y, Scott K, Lindh CH, Jakobsson K, Fletcher T, Ohlsson B, Andersson EM. Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water. Environ Res 2020;181:108923. [PMID: 31759646 DOI: 10.1016/j.envres.2019.108923] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
221 Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11:649-670. [PMID: 28158501 DOI: 10.1093/ecco-jcc/jjx008] [Cited by in Crossref: 682] [Cited by in F6Publishing: 510] [Article Influence: 227.3] [Reference Citation Analysis]
222 Feuerstein JD, Moss AC, Farraye FA. Ulcerative Colitis. Mayo Clin Proc. 2019;94:1357-1373. [PMID: 31272578 DOI: 10.1016/j.mayocp.2019.01.018] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 54.0] [Reference Citation Analysis]
223 Nyboe Andersen N, Gørtz S, Frisch M, Jess T. Reduced risk of UC in families affected by appendicitis: a Danish national cohort study. Gut 2017;66:1398-402. [DOI: 10.1136/gutjnl-2015-311131] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
224 Nie JY, Zhao Q. Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies. Medicine (Baltimore) 2017;96:e9070. [PMID: 29245319 DOI: 10.1097/MD.0000000000009070] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
225 Dutta AK, Chacko A. Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol. 2016;22:1088-1100. [PMID: 26811649 DOI: 10.3748/wjg.v22.i3.1088] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
226 Roosenboom B, Lochem EGV, Meijer J, Smids C, Nierkens S, Brand EC, Erp LWV, Kemperman LGJM, Groenen MJM, Horje CSHT, Wahab PJ. Development of Mucosal PNAd+ and MAdCAM-1+ Venules during Disease Course in Ulcerative Colitis. Cells 2020;9:E891. [PMID: 32268498 DOI: 10.3390/cells9040891] [Reference Citation Analysis]
227 Steenland K, Zhao L, Winquist A, Parks C. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect 2013;121:900-5. [PMID: 23735465 DOI: 10.1289/ehp.1206449] [Cited by in Crossref: 84] [Cited by in F6Publishing: 68] [Article Influence: 10.5] [Reference Citation Analysis]
228 Linares-pineda TM, Cañadas-garre M, Sánchez-pozo A, Calleja-hernández MÁ. Pharmacogenetic biomarkers of response in Crohn’s disease. Pharmacogenomics J 2018;18:1-13. [DOI: 10.1038/tpj.2017.27] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
229 Olafsson S, McIntyre RE, Coorens T, Butler T, Jung H, Robinson PS, Lee-Six H, Sanders MA, Arestang K, Dawson C, Tripathi M, Strongili K, Hooks Y, Stratton MR, Parkes M, Martincorena I, Raine T, Campbell PJ, Anderson CA. Somatic Evolution in Non-neoplastic IBD-Affected Colon. Cell 2020;182:672-684.e11. [PMID: 32697969 DOI: 10.1016/j.cell.2020.06.036] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 34.0] [Reference Citation Analysis]
230 Pearce FA, Lanyon PC, Watts RA, Grainge MJ, Abhishek A, Hubbard RB. Novel insights into the aetiology of granulomatosis with polyangiitis-a case-control study using the Clinical Practice Research Datalink. Rheumatology (Oxford) 2018;57:1002-10. [PMID: 29529281 DOI: 10.1093/rheumatology/kex512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
231 Kong L, Wang L, Meng F, Cao J, Shen Y. Association between smoking and risk of knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis and Cartilage 2017;25:809-16. [DOI: 10.1016/j.joca.2016.12.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
232 Collett A, Higgs NB, Gironella M, Zeef LA, Hayes A, Salmo E, Haboubi N, Iovanna JL, Carlson GL, Warhurst G. Early molecular and functional changes in colonic epithelium that precede increased gut permeability during colitis development in mdr1a(-/-) mice. Inflamm Bowel Dis. 2008;14:620-631. [PMID: 18275070 DOI: 10.1002/ibd.20375] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
233 Kuenzig ME, Yim J, Coward S, Eksteen B, Seow CH, Barnabe C, Barkema HW, Silverberg MS, Lakatos PL, Beck PL, Fedorak R, Dieleman LA, Madsen K, Panaccione R, Ghosh S, Kaplan GG. The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study. EBioMedicine 2017;21:188-96. [PMID: 28668336 DOI: 10.1016/j.ebiom.2017.06.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
234 Vrablicova Z, Soltys K, Krajcovicova A, Stuchlikova K, Sturdik I, Koller T, Huorka M, Payer J, Killinger Z, Jackuliak P, Tkacik M, Stuchlik S, Sekac J, Hlavaty T. Impact of smoking cigarette on the mRNA expression of cytokines in mucosa of inflammatory bowel disease. Physiol Res 2019;68:S183-92. [PMID: 31842582 DOI: 10.33549/physiolres.934301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
235 Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017;112:241-258. [PMID: 28071656 DOI: 10.1038/ajg.2016.537] [Cited by in Crossref: 218] [Cited by in F6Publishing: 150] [Article Influence: 54.5] [Reference Citation Analysis]
236 Parkes GC, Whelan K, Lindsay JO. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis 2014;8:717-25. [PMID: 24636140 DOI: 10.1016/j.crohns.2014.02.002] [Cited by in Crossref: 142] [Cited by in F6Publishing: 119] [Article Influence: 20.3] [Reference Citation Analysis]
237 Andersen AB, Ehrenstein V, Erichsen R, Frøslev T, Sørensen HT. Parental inflammatory bowel disease and risk of asthma in offspring: a nationwide cohort study in denmark. Clin Transl Gastroenterol 2013;4:e41. [PMID: 23965919 DOI: 10.1038/ctg.2013.12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
238 Parks CG, Miller FW, Pollard KM, Selmi C, Germolec D, Joyce K, Rose NR, Humble MC. Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease. Int J Mol Sci 2014;15:14269-97. [PMID: 25196523 DOI: 10.3390/ijms150814269] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
239 Plevinsky JM, Maddux MH, Greenley RN. Substance Use in Adolescents and Young Adults With Inflammatory Bowel Diseases: An Exploratory Cluster Analysis. J Pediatr Gastroenterol Nutr 2019;69:324-9. [PMID: 30985442 DOI: 10.1097/MPG.0000000000002365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
240 Nos P, Domènech E. Management of Crohn's disease in smokers: is an alternative approach necessary? World J Gastroenterol 2011;17:3567-74. [PMID: 21987601 DOI: 10.3748/wjg.v17.i31.3567] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
241 Zareef R, Younis N, Mahfouz R. Inflammatory bowel disease: A key role for microbiota? Meta Gene 2020;25:100713. [DOI: 10.1016/j.mgene.2020.100713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
242 Bae JM, Choo JY, Kim KJ, Park KS. Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: A nationwide population-based study. Mod Rheumatol 2017;27:435-40. [PMID: 27459267 DOI: 10.1080/14397595.2016.1211229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
243 Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205-217. [PMID: 25732745 DOI: 10.1038/nrgastro.2015.34] [Cited by in Crossref: 662] [Cited by in F6Publishing: 563] [Article Influence: 110.3] [Reference Citation Analysis]
244 Khalili H, Higuchi LM, Ananthakrishnan AN, Richter JM, Feskanich D, Fuchs CS, Chan AT. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut. 2013;62:1153-1159. [PMID: 22619368 DOI: 10.1136/gutjnl-2012-302362] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 11.3] [Reference Citation Analysis]
245 Park SJ, Kim WH, Cheon JH. Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives. World J Gastroenterol 2014;20:11525-37. [PMID: 25206259 DOI: 10.3748/wjg.v20.i33.11525] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 10.8] [Reference Citation Analysis]
246 Yu HC, Chen TP, Chang YC. Inflammatory bowel disease as a risk factor for periodontitis under Taiwanese National Health Insurance Research database. J Dent Sci 2018;13:242-7. [PMID: 30895127 DOI: 10.1016/j.jds.2018.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
247 Talbot J, Peres RS, Pinto LG, Oliveira RDR, Lima KA, Donate PB, Silva JR, Ryffel B, Cunha TM, Alves-Filho JC, Liew FY, Louzada-Junior P, de Queiroz Cunha F. Smoking-induced aggravation of experimental arthritis is dependent of aryl hydrocarbon receptor activation in Th17 cells. Arthritis Res Ther 2018;20:119. [PMID: 29884199 DOI: 10.1186/s13075-018-1609-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
248 Wang S, Yao L, Liu Y. Fecal microbiome from patients with ulcerative colitis is potent to induce inflammatory responses. International Immunopharmacology 2018;59:361-8. [DOI: 10.1016/j.intimp.2018.04.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
249 Hsieh H, Morin J, Filliettaz C, Varada R, Labarre S, Radi Z. Fecal Lipocalin-2 as a Sensitive and Noninvasive Biomarker in the TNBS Crohn’s Inflammatory Bowel Disease Model. Toxicol Pathol 2016;44:1084-94. [DOI: 10.1177/0192623316665927] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
250 Mark-Christensen A, Erichsen R, Brandsborg S, Rosenberg J, Qvist N, Thorlacius-Ussing O, Hillingsø J, Pachler JH, Christiansen EG, Laurberg S. Long-term Risk of Cancer Following Ileal Pouch-anal Anastomosis for Ulcerative Colitis. J Crohns Colitis 2018;12:57-62. [PMID: 28981638 DOI: 10.1093/ecco-jcc/jjx112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
251 Jones DT, Osterman MT, Bewtra M, Lewis JD. Passive smoking and inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103:2382-2393. [PMID: 18844625 DOI: 10.1111/j.1572-024] [Reference Citation Analysis]
252 Lewis JD, Abreu MT. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. Gastroenterology. 2017;152:398-414.e6. [PMID: 27793606 DOI: 10.1053/j.gastro.2016.10.019] [Cited by in Crossref: 142] [Cited by in F6Publishing: 120] [Article Influence: 28.4] [Reference Citation Analysis]
253 Ducharme-bénard S, Côté-daigneault J, Lemoyne M, Orlicka K, Lahaie R, Weber A, Bouin M. Patients With Inflammatory Bowel Disease Are Unaware of the Impact of Smoking on Their Disease. Journal of Clinical Gastroenterology 2016;50:490-7. [DOI: 10.1097/mcg.0000000000000386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
254 Lee HS, Cleynen I. Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making? Cells. 2019;8. [PMID: 31167397 DOI: 10.3390/cells8060535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
255 Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM, De Roos AJ. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun. 2012;39:259-271. [PMID: 22739348 DOI: 10.1016/j.jaut.2012.05.002] [Cited by in Crossref: 194] [Cited by in F6Publishing: 161] [Article Influence: 21.6] [Reference Citation Analysis]
256 Opstelten JL, Plassais J, van Mil SW, Achouri E, Pichaud M, Siersema PD, Oldenburg B, Cervino AC. Gut Microbial Diversity Is Reduced in Smokers with Crohn's Disease. Inflamm Bowel Dis 2016;22:2070-7. [PMID: 27542127 DOI: 10.1097/MIB.0000000000000875] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 15.7] [Reference Citation Analysis]
257 Sun LP, Lv W, Liang YB, Friedman DS, Yang XH, Guo LX, Peng Y, Wang NL, Wang JJ. The prevalence of and risk factors associated with pterygium in a rural adult Chinese population: the Handan Eye Study. Ophthalmic Epidemiol 2013;20:148-54. [PMID: 23662799 DOI: 10.3109/09286586.2013.763991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
258 Zhai H, Huang W, Liu A, Li Q, Hao Q, Ma L, Yang F, Zhang S. Current smoking improves ulcerative colitis patients' disease behaviour in the northwest of China. Prz Gastroenterol 2017;12:286-90. [PMID: 29358998 DOI: 10.5114/pg.2017.72104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
259 Cioffi M, Rosa AD, Serao R, Picone I, Vietri MT. Laboratory markers in ulcerative colitis: Current insights and future advances. World J Gastrointest Pathophysiol. 2015;6:13-22. [PMID: 25685607 DOI: 10.4291/wjgp.v6.i1.13] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 41] [Article Influence: 8.5] [Reference Citation Analysis]
260 Walsh A, Mabee J, Trivedi K. Inflammatory bowel disease. Prim Care. 2011;38:415-32; vii. [PMID: 21872089 DOI: 10.1016/j.pop.2011.06.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
261 Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011;106 Suppl 1:S2-S25; quiz S26. [PMID: 21472012 DOI: 10.1038/ajg.2011.58] [Cited by in Crossref: 177] [Cited by in F6Publishing: 155] [Article Influence: 17.7] [Reference Citation Analysis]
262 Maruta K, Watanabe C, Hozumi H, Kurihara C, Furuhashi H, Takajo T, Okada Y, Shirakabe K, Higashiyama M, Komoto S, Tomita K, Nagao S, Ishizuka T, Miura S, Hokari R. Nicotine treatment ameliorates DSS-induced colitis by suppressing MAdCAM-1 expression and leukocyte recruitment. J Leukoc Biol 2018;104:1013-22. [PMID: 29901817 DOI: 10.1002/JLB.3A0717-304R] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
263 Nunes T, Etchevers MJ, Merino O, Gallego S, García-Sánchez V, Marín-Jiménez I, Menchén L, Barreiro-de Acosta M, Bastida G, García S. High smoking cessation rate in Crohn’s disease patients after physician advice--the TABACROHN Study. J Crohns Colitis. 2013;7:202-207. [PMID: 22626507 DOI: 10.1016/j.crohns.2012.04.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
264 Yadav P, Ellinghaus D, Rémy G, Freitag-Wolf S, Cesaro A, Degenhardt F, Boucher G, Delacre M, Peyrin-Biroulet L, Pichavant M, Rioux JD, Gosset P, Franke A, Schumm LP, Krawczak M, Chamaillard M, Dempfle A, Andersen V; International IBD Genetics Consortium. Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice. Gastroenterology 2017;153:550-65. [PMID: 28506689 DOI: 10.1053/j.gastro.2017.05.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
265 Quezada SM, Langenberg P, Cross RK. Cigarette smoking adversely affects disease activity and disease-specific quality of life in patients with Crohn's disease at a tertiary referral center. Clin Exp Gastroenterol 2016;9:307-10. [PMID: 27703391 DOI: 10.2147/CEG.S104652] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
266 Schiffenbauer A, Faghihi-Kashani S, O'Hanlon TP, Flegel WA, Adams SD, Targoff IN, Oddis CV, Ytterberg SR, Aggarwal R, Christopher-Stine L, Shamim EA, Dellaripa PF, Danoff SK, Mammen AL, Miller FW. The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis. Semin Arthritis Rheum 2018;48:504-12. [PMID: 29703532 DOI: 10.1016/j.semarthrit.2018.02.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
267 van der Sloot KWJ, Amini M, Peters V, Dijkstra G, Alizadeh BZ. Inflammatory Bowel Diseases: Review of Known Environmental Protective and Risk Factors Involved. Inflamm Bowel Dis. 2017;23:1499-1509. [PMID: 28777099 DOI: 10.1097/mib.0000000000001217] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 13.3] [Reference Citation Analysis]
268 Savin Z, Kivity S, Yonath H, Yehuda S. Smoking and the intestinal microbiome. Arch Microbiol 2018;200:677-84. [DOI: 10.1007/s00203-018-1506-2] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 28.3] [Reference Citation Analysis]
269 Chartier LC, Howarth GS, Trinder D, Mashtoub S. Emu oil and grape seed extract reduce tumour burden and disease parameters in murine colitis-associated colorectal cancer. Carcinogenesis 2021;42:202-9. [PMID: 32940671 DOI: 10.1093/carcin/bgaa099] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
270 Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline. Z Gastroenterol 2020;58:e241-326. [PMID: 33260237 DOI: 10.1055/a-1296-3444] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
271 Gustavsson A, Magnuson A, Blomberg B, Andersson M, Halfvarson J, Tysk C. Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn’s disease. Aliment Pharmacol Ther. 2013;37:430-437. [PMID: 23205619 DOI: 10.1111/apt.12176] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
272 Zhang Y, Zeng C, Li H, Yang T, Deng ZH, Yang Y, Ding X, Xie DX, Wang YL, Lei GH. Relationship between cigarette smoking and radiographic knee osteoarthritis in Chinese population: a cross-sectional study. Rheumatol Int 2015;35:1211-7. [PMID: 25588371 DOI: 10.1007/s00296-014-3202-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
273 Kõks G, Uudelepp ML, Limbach M, Peterson P, Reimann E, Kõks S. Smoking-induced expression of the GPR15 gene indicates its potential role in chronic inflammatory pathologies. Am J Pathol 2015;185:2898-906. [PMID: 26348578 DOI: 10.1016/j.ajpath.2015.07.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
274 Opstelten JL, Chan SSM, Hart AR, van Schaik FDM, Siersema PD, Lentjes EGWM, Khaw KT, Luben R, Key TJ, Boeing H, Bergmann MM, Overvad K, Palli D, Masala G, Racine A, Carbonnel F, Boutron-Ruault MC, Tjønneland A, Olsen A, Andersen V, Kaaks R, Kühn T, Tumino R, Trichopoulou A, Peeters PHM, Verschuren WMM, Witteman BJM, Oldenburg B. Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis in European Populations: A Nested Case-Control Study. Inflamm Bowel Dis 2018;24:633-40. [PMID: 29462382 DOI: 10.1093/ibd/izx050] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
275 Ginsberg GM, Geva H. The burden of smoking in Israel-attributable mortality and costs (2014). Isr J Health Policy Res 2014;3:28. [PMID: 25258677 DOI: 10.1186/2045-4015-3-28] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
276 Spehlmann ME, Begun AZ, Burghardt J, Lepage P, Raedler A, Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis 2008;14:968-76. [PMID: 18253950 DOI: 10.1002/ibd.20380] [Cited by in Crossref: 106] [Cited by in F6Publishing: 89] [Article Influence: 8.2] [Reference Citation Analysis]
277 Bhat M, Nguyen GC, Pare P, Lahaie R, Deslandres C, Bernard EJ, Aumais G, Jobin G, Wild G, Cohen A, Langelier D, Brant S, Dassopoulos T, McGovern D, Torres E, Duerr R, Regueiro M, Silverberg MS, Steinhart H, Griffiths AM, Elkadri A, Cho J, Proctor D, Goyette P, Rioux J, Bitton A. Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository. Am J Gastroenterol 2009;104:2233-40. [PMID: 19513023 DOI: 10.1038/ajg.2009.267] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
278 Scaldaferri F, Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis. 2007;8:171-178. [PMID: 17970872 DOI: 10.1111/j.1751-2980.2007.00310.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 7.3] [Reference Citation Analysis]
279 Ballester Ferré MP, Boscá-Watts MM, Mínguez Pérez M. Crohn's disease. Med Clin (Barc) 2018;151:26-33. [PMID: 29246562 DOI: 10.1016/j.medcli.2017.10.036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
280 Lo CH, Khalili H, Lochhead P, Song M, Lopes EW, Burke KE, Richter JM, Chan AT, Ananthakrishnan AN. Immune-mediated diseases and risk of Crohn's disease or ulcerative colitis: a prospective cohort study. Aliment Pharmacol Ther 2021;53:598-607. [PMID: 33280139 DOI: 10.1111/apt.16210] [Reference Citation Analysis]
281 Barthel C, Wiegand S, Scharl S, Scharl M, Frei P, Vavricka SR, Fried M, Sulz MC, Wiegand N, Rogler G, Biedermann L. Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?--a patient survey. Nutr J 2015;14:78. [PMID: 26265051 DOI: 10.1186/s12937-015-0070-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
282 Sharma A, Chinn BT. Preoperative optimization of crohn disease. Clin Colon Rectal Surg 2013;26:75-9. [PMID: 24436653 DOI: 10.1055/s-0033-1348044] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
283 Nielsen OH, Bjerrum JT, Seidelin JB, Nyberg C, Ainsworth M. Biological treatment of Crohn’s disease. Dig Dis. 2012;30 Suppl 3:121-133. [PMID: 23295703 DOI: 10.1159/000342738] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
284 Thia KT, Loftus EV, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167-3182. [PMID: 19086963 DOI: 10.1111/j.1572-0241.2008.02158.x] [Cited by in Crossref: 337] [Cited by in F6Publishing: 325] [Article Influence: 28.1] [Reference Citation Analysis]
285 Zhornitskiy A, Shen S, Le LB, Fung BM, Zhornitsky F, Liang T, Limketkai BN, Sauk JS, Tabibian JH. Rates of inflammatory bowel disease in Hispanics comparable to non-Hispanic Whites: results of a cohort study. Int J Colorectal Dis 2021;36:1043-51. [PMID: 33410997 DOI: 10.1007/s00384-020-03819-0] [Reference Citation Analysis]
286 Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965-990. [PMID: 23040452 DOI: 10.1016/j.crohns.2012.09.003] [Cited by in Crossref: 539] [Cited by in F6Publishing: 452] [Article Influence: 59.9] [Reference Citation Analysis]
287 Kuenzig ME, Bishay K, Leigh R, Kaplan GG, Benchimol EI; Crowdscreen SR Review Team. Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. Clin Transl Gastroenterol 2018;9:188. [PMID: 30250122 DOI: 10.1038/s41424-018-0054-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
288 Papageorgiou SN, Hagner M, Nogueira AVB, Franke A, Jäger A, Deschner J. Inflammatory bowel disease and oral health: systematic review and a meta-analysis. J Clin Periodontol 2017;44:382-93. [DOI: 10.1111/jcpe.12698] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 15.0] [Reference Citation Analysis]
289 Kuenzig ME, Barnabe C, Seow CH, Eksteen B, Negron ME, Rezaie A, Panaccione R, Benchimol EI, Sadatsafavi M, Aviña-Zubieta JA, Kaplan GG. Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case-Control Study. Clin Gastroenterol Hepatol 2017;15:1405-1412.e3. [PMID: 28344063 DOI: 10.1016/j.cgh.2017.02.042] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
290 Magyari L, Faragó B, Bene J, Horvatovich K, Lakner L, Varga M, Figler M, Gasztonyi B, Mózsik G, Melegh B. No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn’s disease and ulcerative colitis in Hungarian population samples. World J Gastroenterol. 2007;13:2205-2208. [PMID: 17465502 DOI: 10.3748/wjg.v13.i15.2205] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
291 Selby L, Kane S, Wilson J, Balla P, Riff B, Bingcang C, Hoellein A, Pande S, de Villiers WJ. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008;14:253-258. [PMID: 17932966 DOI: 10.1002/ibd.20266] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
292 Lim D, Cho Y, Kim W, Jeong S, Jang YP, Kim J. Original Research: Extract of Bambusae Caulis in Taeniam inhibits cigarette smoke-induced pulmonary and intestinal inflammation. Exp Biol Med (Maywood) 2017;242:102-12. [PMID: 27590499 DOI: 10.1177/1535370216664429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
293 Basson A, Swart R, Jordaan E, Mazinu M, Watermeyer G. The association between childhood environmental exposures and the subsequent development of Crohn's disease in the Western Cape, South Africa. PLoS One 2014;9:e115492. [PMID: 25514591 DOI: 10.1371/journal.pone.0115492] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
294 Kang EA, Chun J, Kim JH, Han K, Soh H, Park S, Hong SW, Moon JM, Lee J, Lee HJ, Park JB, Im JP, Kim JS. Periodontitis combined with smoking increases risk of the ulcerative colitis: A national cohort study. World J Gastroenterol 2020;26:5661-72. [PMID: 33088159 DOI: 10.3748/wjg.v26.i37.5661] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
295 Nadeem MS, Kumar V, Al-abbasi FA, Kamal MA, Anwar F. Risk of colorectal cancer in inflammatory bowel diseases. Seminars in Cancer Biology 2020;64:51-60. [DOI: 10.1016/j.semcancer.2019.05.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 29.0] [Reference Citation Analysis]
296 Wang X, Fan X, Deng H, Zhang X, Zhang K, Xu J, Li N, Han Q, Liu Z. Use of oral contraceptives and risk of ulcerative colitis – A systematic review and meta-analysis. Pharmacological Research 2019;139:367-74. [DOI: 10.1016/j.phrs.2018.11.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
297 Olén O, Askling J, Sachs MC, Frumento P, Neovius M, Smedby KE, Ekbom A, Malmborg P, Ludvigsson JF. Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014. BMJ 2017;358:j3951. [PMID: 28931512 DOI: 10.1136/bmj.j3951] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 16.8] [Reference Citation Analysis]
298 Blackwell J, Saxena S, Petersen I, Hotopf M, Creese H, Bottle A, Alexakis C, Pollok RC; POP-IBD study group. Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case-control study. Gut 2021;70:1642-8. [PMID: 33109601 DOI: 10.1136/gutjnl-2020-322308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
299 Sharara AI, Al Awadhi S, Alharbi O, Al Dhahab H, Mounir M, Salese L, Singh E, Sunna N, Tarcha N, Mosli M. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East. Expert Rev Gastroenterol Hepatol. 2018;12:883-897. [PMID: 30096985 DOI: 10.1080/17474124.2018.1503052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
300 Lai Y, Xue J, Liu CW, Gao B, Chi L, Tu P, Lu K, Ru H. Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn's Disease. Molecules 2019;24:E449. [PMID: 30691236 DOI: 10.3390/molecules24030449] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
301 Le Berre C, Loy L, Lönnfors S, Avedano L, Piovani D. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations. World J Gastroenterol 2020;26:4343-55. [PMID: 32848338 DOI: 10.3748/wjg.v26.i29.4343] [Reference Citation Analysis]
302 Mendall MA, Chan D, Patel R, Kumar D. Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn's Disease. BMC Gastroenterol 2016;16:126. [PMID: 27717310 DOI: 10.1186/s12876-016-0535-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
303 Opstelten JL, Leenders M, Dik VK, Chan SS, van Schaik FD, Khaw KT, Luben R, Hallmans G, Karling P, Lindgren S, Grip O, Key TJ, Crowe FL, Boeing H, Bergmann MM, Overvad K, Palli D, Masala G, Racine A, Carbonnel F, Boutron-Ruault MC, Tjønneland A, Olsen A, Andersen V, Kaaks R, Katzke VA, Tumino R, Trichopoulou A, Siersema PD, Bueno-de-Mesquita HB, Hart AR, Oldenburg B. Dairy Products, Dietary Calcium, and Risk of Inflammatory Bowel Disease: Results From a European Prospective Cohort Investigation. Inflamm Bowel Dis 2016;22:1403-11. [PMID: 27120568 DOI: 10.1097/MIB.0000000000000798] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 15.7] [Reference Citation Analysis]
304 Biedermann L, Brülisauer K, Zeitz J, Frei P, Scharl M, Vavricka SR, Fried M, Loessner MJ, Rogler G, Schuppler M. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm Bowel Dis. 2014;20:1496-1501. [PMID: 25072500 DOI: 10.1097/mib.0000000000000129] [Cited by in Crossref: 89] [Cited by in F6Publishing: 46] [Article Influence: 14.8] [Reference Citation Analysis]
305 Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;5:237-247. [PMID: 23922506 DOI: 10.2147/clep.s33961] [Cited by in Crossref: 35] [Cited by in F6Publishing: 79] [Article Influence: 4.4] [Reference Citation Analysis]
306 Juyal G, Negi S, Sood A, Gupta A, Prasad P, Senapati S, Zaneveld J, Singh S, Midha V, van Sommeren S, Weersma RK, Ott J, Jain S, Juyal RC, Thelma BK. Genome-wide association scan in north Indians reveals three novel HLA-independent risk loci for ulcerative colitis. Gut. 2015;64:571-579. [PMID: 24837172 DOI: 10.1136/gutjnl-2013-306625] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
307 Wang FY, Chi CC. Association of rosacea with inflammatory bowel disease: A MOOSE-compliant meta-analysis. Medicine (Baltimore) 2019;98:e16448. [PMID: 31593075 DOI: 10.1097/MD.0000000000016448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
308 de la Poza G, López-Sanroman A, Taxonera C, Marín-Jimenez I, Gisbert JP, Bermejo F, Opio V, Muriel A. Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy. J Crohns Colitis 2012;6:276-80. [PMID: 22405162 DOI: 10.1016/j.crohns.2011.08.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
309 Lawrance IC, Murray K, Batman B, Gearry RB, Grafton R, Krishnaprasad K, Andrews JM, Prosser R, Bampton PA, Cooke SE, Mahy G, Radford-Smith G, Croft A, Hanigan K. Crohn's disease and smoking: is it ever too late to quit? J Crohns Colitis 2013;7:e665-71. [PMID: 23790611 DOI: 10.1016/j.crohns.2013.05.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
310 Williams MR, Stedtfeld RD, Tiedje JM, Hashsham SA. MicroRNAs-Based Inter-Domain Communication between the Host and Members of the Gut Microbiome. Front Microbiol 2017;8:1896. [PMID: 29021788 DOI: 10.3389/fmicb.2017.01896] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
311 Ananthakrishnan AN. Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci. 2015;60:290-298. [PMID: 25204669 DOI: 10.1007/s10620-014-3350-9] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 11.9] [Reference Citation Analysis]
312 Ungaro R, Chang HL, Côté-Daigneault J, Mehandru S, Atreja A, Colombel JF. Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease. Am J Gastroenterol 2016;111:1416-23. [PMID: 27296939 DOI: 10.1038/ajg.2016.233] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 6.6] [Reference Citation Analysis]
313 Hjern F, Wolk A, Håkansson N. Smoking and the risk of diverticular disease in women. British Journal of Surgery 2011;98:997-1002. [DOI: 10.1002/bjs.7477] [Cited by in Crossref: 75] [Cited by in F6Publishing: 56] [Article Influence: 7.5] [Reference Citation Analysis]
314 Ungaro R, Fausel R, Chang HL, Chang S, Chen LA, Nakad A, El Nawar A, Prytz Berset I, Axelrad J, Lawlor G, Atreja A, Roque Ramos L, Torres J, Colombel JF. Bariatric surgery is associated with increased risk of new-onset inflammatory bowel disease: case series and national database study. Aliment Pharmacol Ther. 2018;47:1126-1134. [PMID: 29512187 DOI: 10.1111/apt.14569] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
315 Naganuma M, Sakuraba A, Hibi T. Ulcerative colitis: prevention of relapse. Expert Rev Gastroenterol Hepatol 2013;7:341-51. [PMID: 23639092 DOI: 10.1586/egh.13.18] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
316 Elhenawy W, Oberc A, Coombes BK. A polymicrobial view of disease potential in Crohn's-associated adherent-invasive E. coli. Gut Microbes 2018;9:166-74. [PMID: 28914579 DOI: 10.1080/19490976.2017.1378291] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
317 Stojsavljević A, Sokić-Milutinović A, Rovčanin B, Tončev L, Manojlović D. Profiling of Circulatory Elements Reveals Alteration of Essential and Toxic Trace Metals in Crohn's Disease. Biol Trace Elem Res 2021. [PMID: 34357515 DOI: 10.1007/s12011-021-02862-4] [Reference Citation Analysis]
318 Andersen V, Chan S, Luben R, Khaw KT, Olsen A, Tjonneland A, Kaaks R, Grip O, Bergmann MM, Boeing H, Hultdin J, Karling P, Overvad K, Oldenburg B, Opstelten J, Boutron-Ruault MC, Carbonnel F, Racine A, Key T, Masala G, Palli D, Tumino R, Trichopoulou A, Riboli E, Hart A. Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD). J Crohns Colitis. 2018;12:129-136. [PMID: 29373726 DOI: 10.1093/ecco-jcc/jjx136] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 12.3] [Reference Citation Analysis]
319 Hill SC, Stavrakoglou A, Coutts IR. Nicotine replacement therapy as a treatment for complex aphthosis. J Dermatolog Treat 2010;21:317-8. [PMID: 19821785 DOI: 10.3109/09546630903271563] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
320 Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, O’Morain C, Moum B, Colombel JF. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630-649. [PMID: 23335431 DOI: 10.1007/s11894-013-0313-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
321 Han DY, Fraser AG, Dryland P, Ferguson LR. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn‘s disease within New Zealand. Mutat Res. 2010;690:116-122. [PMID: 19751746 DOI: 10.1016/j.mrfmmm.2009.09.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
322 Sun W, Han X, Wu S, Yang C. Tonsillectomy and the risk of inflammatory bowel disease: A systematic review and meta-analysis: Tonsillectomy and risk of IBD. Journal of Gastroenterology and Hepatology 2016;31:1085-94. [DOI: 10.1111/jgh.13273] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
323 Goldacre MJ, Wotton CJ, Maisonneuve JJ. Maternal and perinatal factors associated with subsequent meningococcal, Haemophilus or enteroviral meningitis in children: database study. Epidemiol Infect 2014;142:371-8. [PMID: 23659618 DOI: 10.1017/S095026881300099X] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
324 Prager M, Büttner J, Grunert P, Ellinghaus D, Büning C. A Promoter Variant Within the Aryl Hydrocarbon Receptor Gene Is Associated with an Epithelial Barrier Defect in Smokers with Crohn's Disease. Inflamm Bowel Dis 2016;22:2356-68. [PMID: 27598741 DOI: 10.1097/MIB.0000000000000910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
325 Nagao-Kitamoto H, Kitamoto S, Kuffa P, Kamada N. Pathogenic role of the gut microbiota in gastrointestinal diseases. Intest Res. 2016;14:127-138. [PMID: 27175113 DOI: 10.5217/ir.2016.14.2.127] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 14.4] [Reference Citation Analysis]
326 Nunes T, Etchevers MJ, Merino O, Gallego S, García-Sánchez V, Marín-Jiménez I, Menchén L, Barreiro-de Acosta M, Bastida G, García S, Gento E, Ginard D, Gomollón F, Arroyo M, Monfort D, García-Planella E, Gonzalez B, Loras C, Agustí C, Figueroa C, Sans M; TABACROHN Study Group of GETECCU, Spanish Working Group in Crohn's Disease and Ulcerative Colitis. Does smoking influence Crohn's disease in the biologic era? The TABACROHN study. Inflamm Bowel Dis 2013;19:23-9. [PMID: 22467185 DOI: 10.1002/ibd.22959] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
327 Georgiou AN, Ntritsos G, Papadimitriou N, Dimou N, Evangelou E. Cigarette Smoking, Coffee Consumption, Alcohol Intake, and Risk of Crohn's Disease and Ulcerative Colitis: A Mendelian Randomization Study. Inflamm Bowel Dis 2021;27:162-8. [PMID: 32628751 DOI: 10.1093/ibd/izaa152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
328 Day MW. Fight back against inflammatory bowel disease. Nursing 2008;38:34-40. [DOI: 10.1097/01.nurse.0000341077.75953.74] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
329 Connelly TM, Koltun WA. Inflammatory Bowel Disease: Pathobiology. In: Steele SR, Hull TL, Read TE, Saclarides TJ, Senagore AJ, Whitlow CB, editors. The ASCRS Textbook of Colon and Rectal Surgery. Cham: Springer International Publishing; 2016. pp. 749-69. [DOI: 10.1007/978-3-319-25970-3_44] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
330 Lo TC, Chen YY, Chen HH. Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study. Eye (Lond) 2021. [PMID: 34155367 DOI: 10.1038/s41433-021-01645-4] [Reference Citation Analysis]
331 Lucendo AJ, Arias Á, Roncero Ó, Hervías D, Verdejo C, Naveas-Polo C, Bouhmidi A, Lorente R, Alcázar LM, Salueña I, García-Quiñones JA, Carrillo-Ramos MJ. Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients. Dig Liver Dis 2017;49:405-11. [PMID: 28096058 DOI: 10.1016/j.dld.2016.12.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
332 Rasmussen NF, Rubin KH, Stougaard M, Tjønneland A, Stenager E, Lund Hetland M, Glintborg B, Bygum A, Andersen V. Impact of red meat, processed meat and fibre intake on risk of late-onset chronic inflammatory diseases: prospective cohort study on lifestyle factors using the Danish 'Diet, Cancer and Health' cohort (PROCID-DCH): protocol. BMJ Open 2019;9:e024555. [PMID: 30928934 DOI: 10.1136/bmjopen-2018-024555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
333 Friedman A, Gibson P. Inflammatory Bowel Disease – Crohn's Disease and Ulcerative Colitis. Reference Module in Biomedical Sciences. Elsevier; 2014. [DOI: 10.1016/b978-0-12-801238-3.00052-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
334 Porter RJ, Kalla R, Ho GT. Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Res 2020;9:F1000 Faculty Rev-294. [PMID: 32399194 DOI: 10.12688/f1000research.20805.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
335 Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T, Saruta M, Hirai F, Hata K, Hiraoka S, Esaki M, Sugimoto K, Fuji T, Watanabe K, Nakamura S, Inoue N, Itoh T, Naganuma M, Hisamatsu T, Watanabe M, Miwa H, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 2021;56:489-526. [PMID: 33885977 DOI: 10.1007/s00535-021-01784-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
336 Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study. J Crohns Colitis. 2014;8:607-616. [PMID: 24315795 DOI: 10.1016/j.crohns.2013.11.021] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
337 Vatn MH. Environmental Factors in the Epidemiology of Inflammatory Bowel Disease. In: Baumgart DC, editor. Crohn's Disease and Ulcerative Colitis. Boston: Springer US; 2012. pp. 17-38. [DOI: 10.1007/978-1-4614-0998-4_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
338 Heap GA, van Heel DA. The genetics of chronic inflammatory diseases. Hum Mol Genet. 2009;18:R101-R106. [PMID: 19297396 DOI: 10.1093/hmg/ddp001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
339 Missaghi B, Barkema HW, Madsen KL, Ghosh S. Perturbation of the human microbiome as a contributor to inflammatory bowel disease. Pathogens 2014;3:510-27. [PMID: 25438009 DOI: 10.3390/pathogens3030510] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
340 Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, van Assche G. [Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version)]. Rev Gastroenterol Mex 2014;79:263-89. [PMID: 25487134 DOI: 10.1016/j.rgmx.2014.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
341 Etchevers MJ, Jiménez IO. Tabaquismo y enfermedad de Crohn: estrategias de deshabituación. Gastroenterología y Hepatología 2009;32:37-43. [DOI: 10.1016/s0210-5705(09)72604-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
342 Chen CY, Lee KT, Charles Tzu-Chi L, Lai WT, Huang YB. Epidemiology and Disease Burden of Ulcerative Colitis in Taiwan: A Nationwide Population-Based Study. Value Health Reg Issues 2013;2:127-34. [PMID: 29702840 DOI: 10.1016/j.vhri.2013.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
343 Braus NA, Elliott DE. Advances in the pathogenesis and treatment of IBD. Clin Immunol. 2009;132:1-9. [PMID: 19321388 DOI: 10.1016/j.clim.2009.02.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
344 Eaton JE, Juran BD, Atkinson EJ, Schlicht EM, Xie X, de Andrade M, Lammert CS, Luketic VA, Odin JA, Koteish AA, Kowdley KV, Chopra KB, Hirschfield GM, Chalasani NP, Lazaridis KN. A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther 2015;41:980-90. [PMID: 25783671 DOI: 10.1111/apt.13154] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
345 Festen EA, Weersma RK. How will insights from genetics translate to clinical practice in inflammatory bowel disease? Best Pract Res Clin Gastroenterol. 2014;28:387-397. [PMID: 24913379 DOI: 10.1016/j.bpg.2014.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
346 van der Sloot KWJ, Tiems JL, Visschedijk MC, Festen EAM, van Dullemen HM, Weersma RK, Kats-Ugurlu G, Dijkstra G. Cigarette Smoke Increases Risk for Colorectal Neoplasia in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00018-5. [PMID: 33453400 DOI: 10.1016/j.cgh.2021.01.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
347 Koutsochristou V, Zellos A, Dimakou K, Panayotou I, Siahanidou S, Roma-Giannikou E, Tsami A. Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case-Control Study. Inflamm Bowel Dis. 2015;21:1839-1846. [PMID: 25985243 DOI: 10.1097/mib.0000000000000452] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
348 Reinisch W, Reinink AR, Higgins PD. Factors associated with poor outcomes in adults with newly diagnosed ulcerative colitis. Clin Gastroenterol Hepatol 2015;13:635-42. [PMID: 24887059 DOI: 10.1016/j.cgh.2014.03.037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
349 Niu J, Miao J, Tang Y, Nan Q, Liu Y, Yang G, Dong X, Huang Q, Xia S, Wang K, Miao Y. Identification of Environmental Factors Associated with Inflammatory Bowel Disease in a Southwestern Highland Region of China: A Nested Case-Control Study. PLoS One 2016;11:e0153524. [PMID: 27070313 DOI: 10.1371/journal.pone.0153524] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
350 Cabré E, Domènech E. Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol. 2012;18:3814-3822. [PMID: 22876032 DOI: 10.3748/wjg.v18.i29.3814] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
351 Li E, Hamm CM, Gulati AS, Sartor RB, Chen H, Wu X, Zhang T, Rohlf FJ, Zhu W, Gu C. Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One. 2012;7:e26284. [PMID: 22719818 DOI: 10.1371/journal.pone.0026284] [Cited by in Crossref: 159] [Cited by in F6Publishing: 134] [Article Influence: 17.7] [Reference Citation Analysis]
352 Jones PD, Kappelman MD, Martin CF, Chen W, Sandler RS, Long MD. Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission. Inflamm Bowel Dis. 2015;21:1063-1071. [PMID: 25723616 DOI: 10.1097/mib.0000000000000333] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 7.4] [Reference Citation Analysis]
353 Al Momani L, Balagoni H, Alomari M, Gaddam S, Boonpherg B, Aasen T, Piper M, Young M. The association between smoking and both types of microscopic colitis: A systematic review and meta-analysis. Arab J Gastroenterol 2020;21:9-18. [PMID: 32241698 DOI: 10.1016/j.ajg.2020.01.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
354 Wang Q, Mi S, Yu Z, Li Q, Lei J. Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease. Can J Gastroenterol Hepatol 2020;2020:7397523. [PMID: 32850517 DOI: 10.1155/2020/7397523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
355 Kim HJ, Oh SH, Kim DY, Lee H, Park SH, Yang S, Kim KM. Clinical Characteristics and Long-Term Outcomes of Paediatric Crohn’s Disease: A Single-Centre Experience. ECCOJC 2017;11:157-64. [DOI: 10.1093/ecco-jcc/jjw146] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
356 Hutfless S, Abramson O, Heyman MB, Bayless TM, Li DK, Winthrop K, Herrinton LJ. Infections Requiring Hospitalization as Predictors of Pediatric-Onset Crohn's Disease and Ulcerative Colitis. Gastroenterol Res Pract 2015;2015:690581. [PMID: 26074957 DOI: 10.1155/2015/690581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
357 Stange EF, Travis SP, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, Feakins R, Fléjou JF, Herfarth H, Hommes DW. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis. 2008;2:1-23. [PMID: 21172194 DOI: 10.1016/j.crohns.2007.11.001] [Cited by in Crossref: 353] [Cited by in F6Publishing: 320] [Article Influence: 27.2] [Reference Citation Analysis]